SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
(Mark One)
þ
|
Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
|
For the quarterly period ended April 2, 2005 |
o
|
Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
|
For the transition period from to |
Commission File Number 0-21074
SUPERCONDUCTOR TECHNOLOGIES INC.
Delaware
(State or other jurisdiction of
incorporation or organization)
77-0158076
(IRS Employer
Identification No.)
460 Ward Drive,
Santa Barbara, California 93111-2356
(Address of principal executive offices & zip code)
(805) 690-4500
(Registrants telephone number including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes þ No o
Indicate by check mark whether the registrant is an accelerated filer (as defined by Rule 12b-2 of the Exchange Act
Yes þ No o
As of May 5, 2005 there were 107,711,026 shares of the Registrants Common Stock outstanding.
1
SUPERCONDUCTOR TECHNOLOGIES INC.
INDEX TO FORM 10-Q
Three Months Ended April 2, 2005
2
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This report contains forward-looking statements that involve risks and uncertainties. We have made these statements in reliance on the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Our forward-looking statements relate to future events or our future performance and include, but are not limited to, statements concerning our business strategy, future commercial revenues, market growth, capital requirements, new product introductions, expansion plans and our funding requirements. Other statements contained in our filings that are not historical facts are also forward-looking statements. We have tried, wherever possible, to identify forward-looking statements by terminology such as may, will, could, should, expects, anticipates, intends, plans, believes, seeks, estimates and other comparable terminology.
Forward-looking statements are not guarantees of future performance and are subject to various risks, uncertainties and assumptions that are difficult to predict. Therefore, actual results may differ materially from those expressed in forward-looking statements. They can be affected by many factors, including, those discussed under the captions Managements Discussion and Analysis of Financial Condition and Results of Operations in this Quarterly Report on Form 10-Q and BusinessAdditional Factors That May Affect Our Future Results in our 2004 Annual Report on Form 10-K. Forward-looking statements are based on information presently available to senior management, and we do not assume any duty to update our forward-looking statements.
WHERE YOU CAN FIND MORE INFORMATION
As a public company, we are required to file annually, quarterly and special reports, proxy statements and other information with the SEC. You may read and copy any of our materials on file with the SEC at the SECs Public Reference Room at 450 Fifth Street, N.W., Judiciary Plaza, Washington, DC 20549, as well as at the SECs regional office at 5757 Wilshire Boulevard, Suite 500, Los Angeles, California 90036. Our filings are available to the public over the Internet at the SECs website at http:\\.www.sec.gov. Please call the SEC at 1-800-SEC-0330 for further information on the Public Reference Room. We also provide copies of our Forms 8-K, 10-K, 10-Q, Proxy and Annual Report at no charge to investors upon request and make electronic copies of our most recently filed reports available through our website at www.suptech.com as soon as reasonably practicable after filing such material with the SEC.
3
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
SUPERCONDUCTOR TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
See accompanying notes to the condensed consolidated financial statements
4
SUPERCONDUCTOR TECHNOLOGIES INC.
See accompanying notes to the condensed consolidated financial statements
5
SUPERCONDUCTOR TECHNOLOGIES INC.
See accompanying notes to the condensed consolidated financial statements.
6
SUPERCONDUCTOR TECHNOLOGIES INC.
NOTES TO UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
UNAUDITED
1. General
Superconductor Technologies Inc. (the Company) was incorporated in Delaware on May 11, 1987
and maintains its headquarters in Santa Barbara, California. The Company has operated in a single
industry segment, the research, development, manufacture and marketing of high-performance filters
to service providers and original equipment manufacturers in the mobile wireless communications
industry. The Companys research and development contracts are used as a source of funds for its
commercial technology development. The Companys principal commercial product, the
SuperLink
Ò
, combines high-temperature superconductors with cryogenic cooling technology to
produce a filter with significant advantages over conventional filters. From 1987 to 1997, the
Company was engaged primarily in research and development and generated revenues primarily from
government research contracts.
The Company continues to be involved as either contractor or subcontractor on a number of
contracts with the United States government. These contracts have been and continue to provide a
significant source of revenues for the Company. For the three months ended April 3, 2004 and April
2, 2005, government related contracts account for 41% and 13%, respectively, of the Companys net
revenues.
The unaudited consolidated financial information furnished herein has been prepared in
accordance with generally accepted accounting principles and reflects all adjustments, consisting
only of normal recurring adjustments, which in the opinion of management, are necessary for a fair
statement of the results of operations for the periods presented.
The preparation of financial statements in conformity with generally accepted accounting
principles requires management to make estimates and assumptions that affect the amounts reported
in the financial statements and the accompanying notes. Actual results could differ from those
estimates and such differences may be material to the financial statements. This quarterly report
on Form 10-Q should be read in conjunction with the Companys Form 10-K for the year ended December
31, 2004. The results of operations for the three months ended April 2, 2005 are not necessarily
indicative of results for the entire fiscal year ending December 31, 2005.
2. Summary of Significant Accounting Policies
Basis of Presentation
In 2004, the Company incurred a net loss of $31,217,000 and negative cash flows from
operations of $21,580,000. In response, the Company reduced direct and indirect labor and cut
fixed costs. The Company also consolidated its operations in Sunnyvale into its Santa Barbara
facility and accelerated the implementation of a new lower cost wafer deposition process. In the
first quarter of 2005, the Company incurred a net loss of $5,537,000 and negative cash flows from
operations of $4,198,000.
The principal sources of the Companys liquidity consists of existing cash balances and funds
expected to be generated from future operations. The Company believes that its existing cash
resources, together with its line of credit and a planned inventory reduction, will be sufficient
to fund its planned operations for at least the next twelve months. The Company has more inventory
than required for current sales volumes and plans to use its excess inventory as a material source
of funding in 2005. The Company believes the key factors to its liquidity in 2005 will be its
ability to successfully execute on its plans to increase sales levels and to convert excess
inventory to cash. There is no assurance that the Company will be able to increase sales levels or
to sell excess inventory. Its cash requirements will also depend on numerous other variable
factors, including the rate of growth of sales, the timing and levels of products purchased,
payment terms and credit limits from manufacturers, and the timing and level of accounts receivable
collections.
If actual cash flows deviate significantly from forecasted amounts, the Company may require
additional financing in the next twelve months. There is no assurance that additional financing
(public or private) will be available on acceptable terms
7
or at all. If the Company issues additional equity securities to raise funds, the ownership
percentage of its existing stockholders would be reduced. New investors may demand rights,
preferences or privileges senior to those of existing holders of common stock. If the Company
cannot raise any needed funds, it might be forced to make further substantial reductions in its
operating expenses, which could adversely affect its ability to implement its current business plan
and ultimately its viability as a company.
The Companys financial statements have been prepared assuming that it will continue as a
going concern. The factors described above raise substantial doubt about its ability to continue
as a going concern. These financial statements do not include any adjustments that might result
from this uncertainty.
Principles of Consolidation
The interim condensed consolidated financial statements include the accounts of Superconductor
Technologies Inc. and its wholly owned subsidiaries . All significant intercompany transactions
have been eliminated from the consolidated financial statements.
Cash and Cash Equivalents
Cash and cash equivalents consist of highly liquid investments with original maturities of
three months or less. Cash and cash equivalents are maintained with quality financial institutions
and from time to time exceed FDIC limits.
Accounts Receivable
The Company sells predominantly to entities in the wireless communications industry and to
entities of the United States government. The Company grants uncollateralized credit to its
customers. The Company performs ongoing credit evaluations of its customers before granting credit.
Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The
allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our
existing accounts receivable. The Company determines the allowance based on historical write-off
experience. Past due balances are reviewed for collectibility. Accounts balances are charged off
against the allowance when the Company deems it is probable the receivable will not be recovered.
The Company does not have any off balance sheet credit exposure related to its customers.
Revenue Recognition
Commercial revenues are principally derived from the sale of the Companys SuperLink®,
AmpLink, and SuperPlex products and are recognized once all of the following conditions have been
met: a) an authorized purchase order has been received in writing, b) customers credit worthiness
has been established, c) shipment of the product has occurred, d) title has transferred, and e) if
stipulated by the contract, customer acceptance has occurred and all significant vendor
obligations, if any, have been satisfied.
Contract revenues are principally generated under research and development contracts.
Contract revenues are recognized utilizing the percentage-of-completion method measured by the
relationship of costs incurred to total estimated contract costs. If the current contract estimate
were to indicate a loss, utilizing the funded amount of the contract, a provision would be made for
the total anticipated loss. Revenues from research related activities are derived primarily from
contracts with agencies of the United States Government. Credit risk related to accounts
receivable arising from such contracts is considered minimal. These contracts include cost-plus,
fixed price and cost sharing arrangements and are generally short-term in nature.
All payments to the Company for work performed on contracts with agencies of the U.S.
Government are subject to adjustment upon audit by the Defense Contract Audit Agency. Contract
audits through 2002 are closed. Based on historical experience and review of current projects in
process, management believes that the audits will not have a significant effect on the financial
position, results of operations or cash flows of the Company.
Warranties
The Company offers warranties generally ranging from one to five years, depending on the
product and negotiated terms of purchase agreements with its customers. Such warranties require
the Company to repair or replace defective product returned to the Company during such warranty
period at no cost to the customer. An estimate by the Company for warranty related costs is
recorded by the Company at the time of sale based on its actual historical product return rates and
expected repair costs. Such costs have been within managements expectations.
8
Guarantees
In connection with the sales and manufacturing of its commercial products, the Company
indemnifies, without limit or term, its customers and contract manufactures against all claims,
suits, demands, damages, liabilities, expenses, judgments, settlements and penalties arising from
actual or alleged infringement or misappropriation of any intellectual property relating to its
products or other claims arising from its products. The Company cannot reasonably develop an
estimate of the maximum potential amount of payments that might be made under its guarantee because
of the uncertainty as to whether a claim might arise and how much it might total. Historically, the
Company has not incurred any expenses related to these guarantees.
Research and Development Costs
Research and development costs are expensed as incurred and include salary, facility,
depreciation and material expenses. Research and development costs incurred solely in connection
with research and development contracts are charged to contract research and development expense.
Other research and development costs are charged to other research and development expense.
Inventories
Inventories are stated at the lower of cost or market, with costs primarily determined using
standard costs, which approximate actual costs utilizing the first-in, first-out method. Provision
for potentially obsolete or slow moving inventory is made based on managements analysis of
inventory levels and sales forecasts. Costs associated with idle capacity are expensed immediately.
Property and Equipment
Property and equipment are recorded at cost. Equipment is depreciated using the straight-line
method over their estimated useful lives ranging from three to five years. Leasehold improvements
and assets financed under capital leases are amortized over the shorter of their useful lives or
the lease term. Furniture and fixtures are depreciated over seven years. Expenditures for additions
and major improvements are capitalized. Expenditures for minor tooling, repairs and maintenance
and minor improvements are charged to expense as incurred. When property or equipment is retired
or otherwise disposed of, the related cost and accumulated depreciation are removed from the
accounts. Gains or losses from retirements and disposals are recorded as other income or expense.
Patents, Licenses and Purchased Technology
Patents and licenses are recorded at cost and are amortized using the straight-line method
over the shorter of their estimated useful lives or approximately seventeen years. Purchased
technology acquired through the acquisition of Conductus, Inc. is recorded at its estimated fair
value and is amortized using the straight-line method over seven years.
Goodwill
Goodwill represents the excess of purchase price over fair value of net assets acquired in
connection with the acquisition of Conductus in December 2002. Conductus was acquired primarily
for the synergies the acquisition would bring to our existing business of developing, manufacturing
and marketing products for the commercial wireless telecommunications business and for the
synergies it would have on the Companys fund raising abilities.
Goodwill is tested for impairment annually in the fourth quarter after the annual planning
process, or earlier if events occur which require an impairment analysis be performed. The Company
operates in a single business segment as a single reporting unit. The first step of the impairment
test, used to identify potential impairment, compares the fair value based on market capitalization
of the entire Company with its book value of its net assets, including goodwill. The market
capitalization of the Company is based the closing price of its common stock as traded on NASDAQ
multiplied by its outstanding common shares. If the fair value of the Company exceeds the book
value of its net assets, goodwill of the Company is not considered impaired. If the book value of
the net assets of the Company exceeds its fair value, the second step of the goodwill impairment
test shall be performed to measure the amount of impairment loss. The second step of the goodwill
impairment test, used to measure the amount of impairment loss, compares the implied fair value of
the goodwill with the book value of that goodwill. If the carrying amount of the reporting unit
goodwill exceeds the implied fair value of that goodwill, an impairment loss shall be recognized in
an amount equal to that excess. At December 31, 2004, the fair value of the Company based on its
market capitalization totaled $149.7 million, which was in excess of the total book value of the
Company. Therefore, the Companys goodwill was not
9
considered impaired.
Long-Lived Assets
The realizability of long-lived assets is evaluated periodically as events or circumstances
indicate a possible inability to recover the carrying amount. Long-lived assets that will no longer
be used in business are written off in the period identified since they will no longer generate any
positive cash flows for the Company. Periodically, long lived assets that will continue to be used
by the Company need to be evaluated for recoverability. Such evaluation is based on various
analyses, including cash flow and profitability projections. The analyses necessarily involve
significant management judgment. In the event the projected undiscounted cash flows are less than
net book value of the assets, the carrying value of the assets will be written down to their
estimated fair value. The Company completed such an analysis as of the fourth quarter of 2004 and
determined that no write down was necessary.
Restructuring Expenses
Liability for costs associated with an exit or disposal activity are recognized when the
liability is incurred.
Loss Contingencies
In the normal course of business the Company is subject to claims and litigation, including
allegations of patent infringement. Liabilities relating to these claims are recorded when it is
determined that a loss is probable and the amount of the loss can be reasonably estimated. The
costs of defending the Company in such matters are expensed as incurred. Insurance proceeds
recoverable are recorded when deemed probable.
Income Taxes
The Company accounts for income taxes under the provisions of Statement of Financial
Accounting Standards No. 109 (SFAS 109), Accounting for Income Taxes. SFAS 109 utilizes an
asset and liability approach that requires the recognition of deferred tax assets and liabilities
for the expected future tax consequences of events that have been recognized in the Companys
financial statements or tax returns. In estimating future tax consequences, SFAS 109 generally
considers all expected future events other than enactments of changes in the tax laws or rates.
Valuation allowances are established when necessary to reduce deferred tax assets to the amount
expected to be realized.
Marketing Costs
All costs related to marketing and advertising the Companys products are expensed as incurred
or at the time the advertising takes place. Advertising costs were not material in each of the
quarters ended April 3, 2004 and April 2, 2005.
Net Loss Per Share
Basic and diluted net loss per share is computed by dividing net loss available to common
stockholders by the weighted average number of common shares outstanding in each period.
Potentially dilutive shares are not included in the calculation of diluted loss per share because
their effect is antidilutive.
Stock-based Compensation
As permitted under Statement of Financial Accounting Standards No. 123 (SFAS 123),
Accounting for Stock-Based Compensation, the Company has elected to follow Accounting Principles
Board Opinion No. 25, Accounting for Stock Issued to Employees in accounting for its stock
options and other stock-based employee awards. Pro forma information regarding net loss and loss
per share, as calculated under the provisions of SFAS 123, are disclosed in the notes to the
financial statements. The Company accounts for equity securities issued to non-employees in
accordance with the provision of SFAS 123 and Emerging Issues Task Force 96-18.
If the Company had elected to recognize compensation expense for employee awards based upon
the fair value at the grant date consistent with the methodology prescribed by SFAS 123, the
Companys net loss and net loss per share would have been increased to the pro forma amounts
indicated below:
10
Use of Estimates
The preparation of financial statements in conformity with generally accepted accounting
principles requires management to make estimates and assumptions that affect the reported amounts
of assets and liabilities and disclosure of contingent assets and liabilities at the date of the
financial statements and the reported amounts of revenues and expenses during the reporting
periods. The significant estimates in the preparation of the financial statements relate to the
assessment of the carrying amount of accounts receivable, inventory, intangibles, goodwill,
estimated provisions for warranty costs, accruals for restructuring and lease abandonment costs,
income taxes and litigation. Actual results could differ from those estimates and such differences
may be material to the financial statements.
Fair Value of Financial Instruments
The carrying amount of cash and cash equivalents, accounts receivable, accounts payable and
accrued expenses approximate fair value due to the short-term nature of these instruments. The
Company estimates that the carrying amount of the debt approximates fair value based on the
Companys current incremental borrowing rates for similar types of borrowing arrangements.
Comprehensive Income (Loss)
The Company has no items of other comprehensive income (loss) in any period other than its net
loss.
Segment Information
The Company operates in a single business segment, the research, development, manufacture and
marketing of high performance products used in cellular base stations to maximize the performance
of wireless telecommunications networks by improving the quality of uplink signals from mobile
wireless devices. Net commercial product revenues are primarily derived from the sales of the
Companys SuperLink, AmpLink and SuperPlex products. . We currently sell most of our product
directly to wireless network operators in the United States. Net revenues derived principally from
government research and development contracts are presented separately on the statement of
operations for all periods presented. Management views its government research and development
contracts as a supplementary source of revenue to fund its development of high temperature
superconducting products.
Certain Risks and Uncertainties
The Company has continued to incur operating losses. The Companys long-term prospects and
execution of its business plan are dependent upon the continued and increased market acceptance for
the product.
The Company currently sells most of its products directly to wireless network operators in the
United States and its product sales have historically been concentrated in a small number of
customers. In 2004, ALLTEL and Verizon Wireless accounted
11
for 87% of our net commercial revenues and 61% of accounts receivable. In the three months ended
April 2, 2005, ALLTEL and Verizon Wireless accounted for 87% of our commercial revenues and 60% of
accounts receivable. The loss of, or reduction in, sales to either of these customers could have a
material adverse effect on the Companys business, financial condition, results of operations and
cash flows.
The Company currently relies on one supplier for purchases of high quality substrates for
growth of high-temperature superconductor films and a limited number of suppliers for other key
components of its products. The loss of any of these suppliers could have a material adverse effect
on the Companys business, financial condition, results of operations and cash flows.
In connection with the sales of its commercial products, the Company indemnifies, without
limit or term, its customers against all claims, suits, demands, damages, liabilities, expenses,
judgments, settlements and penalties arising from actual or alleged infringement or
misappropriation of any intellectual property relating to its products or other claims arising from
its products. The Company cannot reasonably develop an estimate of the maximum potential amount of
payments that might be made under its guarantee because of the uncertainty as to whether a claim
might arise and how much it might total.
Recent Accounting Pronouncements
In
December 2004, the Financial Accounting Standards Board issued
SFAS No. 123(R) (revised
2004), Share-Based Payment which amends SFAS Statement 123 and will be effective for public
companies for interim periods or annual periods beginning after June 15, 2005. The effective date
was subsequently amended to annual periods beginning after June 15, 2005. The new standard will
require the Company to recognize compensation costs in our financial statements in an amount equal
to the fair value of share-based payments granted to employees and directors. The Company is
currently evaluating how it will adopt the standard and evaluating the effect that the adoption of
SFAS 123(R) will have on it financial position and results of operations
In November 2004, the FASB issued SFAS No. 151, Inventory Costs, an amendment of ARB No. 43,
Chapter 4. This statement amends the guidance in ARB No. 43, Chapter 4, Inventory Pricing, to
clarify the accounting for abnormal amounts of idle facility expense, freight, handling costs, and
wasted material (spoilage). Paragraph 5 of ARB No. 43, Chapter 4, previously stated that ..under
some circumstances, items such as idle facility expense, excessive spoilage, double freight, and
rehandling costs may be so abnormal as to require treatment as current period charges... SFAS No.
151 requires that those items be recognized as current-period charges regardless of whether they
meet the criterion of so abnormal. In addition, this statement requires that allocation of fixed
production overheads to the cost of conversion be based on the normal capacity of the production
facilities. The provisions of SFAS 151 shall be applied prospectively and are effective for
inventory costs incurred during fiscal years beginning after June 15, 2005, with earlier
application permitted for inventory costs incurred during fiscal years beginning after the date
this Statement was issued. The adoption of SFAS No. 151 is not expected to have a material impact
on our financial position and results of operations.
3. Short Term Borrowings
The Company has a line of credit with a bank. The line of credit expires June 15, 2006 and is
structured as a sale of accounts receivable. The agreement provides for the sale of up to $5
million of eligible accounts receivable, with advances to the Company totaling 80% of the
receivables sold. Advances under the agreement are collateralized by all the Companys assets.
Under the terms of the agreement, the Company continues to service the sold receivables and is
subject to recourse provisions.
Advances bear interest at the prime rate (5.75% at April 2, 2005) plus 2.50% subject to a
minimum monthly charge. Outstanding amounts under this borrowing facility at April 2, 2005 totaled
$662,000 and are repaid upon collection of the underlying receivables sold.
The agreement contains representations and warranties, affirmative and negative covenants and
events of default customary for financings of this type. The failure to comply with these
provisions, or the occurrence of any one of the events of default, would prevent any further
borrowings and would generally require the repayment of any outstanding borrowings. Such
representations, warranties and events of default include (a) non-payment of debt and interest
hereunder, (b) non-compliance with terms of the agreement covenants, (c) insolvency or bankruptcy,
(d) material adverse change, (e) merger or consolidation where the Companys shareholders do not
hold a majority of the voting rights of the surviving entity, (f) transactions outside the normal
course of business, or (g) payment of dividends.
4. Retirement of the Companys Chief Executive Officer
12
Effective March 15, 2005, the Companys prior Chief Executive Officer and President retired.
In connection with the retirement, the Company agreed to the continuation of his salary and
benefits for one year and to immediately vest and extend all his outstanding stock options. In
connection with the retirement, a $150,000 loan made to the Companys Chief Executive Officer in
2001, and in accordance with its existing terms which were in effect prior to the adoption of the
Sarbanes-Oxley Act of 2002, this loan was forgiven. The Company recognized expense of $565,000 in
the three months ended April 2, 2005, in connection with the Chief Executive Officers retirement.
5. Stockholders Equity
Stock Options
As of April 2, 2005, the Company had less than 90,000 shares of common stock remaining under
its 2003 Equity Incentive Plan for future equity grants. Therefore, the Company has mailed proxy
statements to its stockholders requesting that they authorize an increase in the total shares
available for grants under the 2003 Equity Plan from 6,000,000 shares of common stock to 12,000,000
shares of common stock. The Company is also requesting a corresponding increase in the related
sublimits under the plan.
During the quarter ended April 2, 2005, the Companys President and Chief Executive Officer,
as well as another board member, retired. In connection with these retirements, the Company
modified the terms of all the stock options held by these individuals to fully vest them and to
extend the term until the earlier of the fifth anniversary of the retirement or the normal
expiration date. Since these options had no intrinsic value at the date of modification, the
modifications did not impact the Companys Statement of Operations.
In connection with the employment agreement of the Companys new President and Chief Executive
Officer, the Company granted a stock option for 1,200,000 shares of stock. The stock option was
granted at 100% of the market value on the date of grant and vests over four years, beginning one
year after the date of grant and expires ten years from the date of grant. Vesting of these options
will accelerate in the event of an involuntary termination or change in control of the Company.
The Company also agreed to issue another option for an additional 1,200,000 shares of common stock
upon stockholder approval of an increase in the shares authorized for grants under the 2003 Equity
Incentive Plan. These options will be granted at 100% of the market value on the date of the
grant. In the event the stockholders do not approve the increase, the Company will grant him
options under the plan as they become available due to expirations of outstanding options.
The following is a summary of stock option transactions under the Companys stock option plans
at April 2, 2005:
The outstanding options expire by the end of April 2015. The exercise prices for these options
range from $0.67 to $49.375 per share, for an aggregate exercise price of approximately $51.3
million. At April 2, 2005, there were 89,478 shares of common stock available for granting future
options.
The fair value of these options for purposes of the pro forma amounts in Note 2 was estimated
at the date of grant using the Black-Scholes option-pricing model with the following
weighted-average assumptions for the three months ended April 3, 2004 and April 2, 2005: dividend
yields of zero percent in each quarter; expected volatilities of 65% and 94%, respectively;
risk-free interest rates of 3.44% and 4.5%, respectively; and expected life of 4.0 years in each
quarter..
The Company also hired a Vice President of Worldwide Sales early in the second quarter of
2005. The Company committed to grant him an option for 1,000,000 shares of common stock upon
stockholder approval of an increase in the shares authorized for grant under the 2003 Equity Plan.
These options will be granted at 100% of the market value on the
13
date of the grant. In the event the stockholders do not approve the increase, the Company will
grant him options under the plan as they become available due to expirations of outstanding
options.
Warrants
The following is a summary of outstanding warrants at April 2, 2005:
6. Legal Proceedings
Patent Litigation
The Company was engaged in a patent dispute with ISCO International, Inc. relating to U.S.
Patent No. 6,263,215 entitled Cryoelectronically Cooled Receiver Front End for Mobile Radio
Systems. ISCO filed a complaint on July 17, 2001 in the United States District Court for the
District of Delaware against us and our wholly-owned subsidiary, Conductus, Inc. The ISCO
complaint alleged that our SuperFilter product and Conductus ClearSite® product infringe ISCOs
patent. The matter went to trial on March 17, 2003.
On April 3, 2003, the jury returned a unanimous verdict that our SuperFilter product does not
infringe the patent in question, and that ISCOs patent is invalid and unenforceable. The jury
also awarded us $3.8 million in compensatory damages based upon a finding that ISCO engaged in
unfair competition and acted in bad faith by issuing press releases and contacting our customers
asserting rights under this patent.
On April 17, 2003, the Company filed a Motion for Attorneys Fees and Disbursements, in which
it asked the court to award it its attorneys fees and other litigation expenses. On the same
date, ISCO filed a motion, asking the court to overturn the verdict and grant a new trial. In
August 2003, the court rejected ISCOs request to overturn the jurys verdict that the patent is
invalid and not infringed by the SuperFilter product, and accepted the jurys verdict that the
patent is unenforceable because of inequitable conduct committed by one of the alleged inventors.
ISCO subsequently filed a notice of appeal as to this portion of the courts decision. The court
overturned the jurys verdict of unfair competition and bad faith on the part of ISCO and the
related $3.8 million compensatory damage award to us, and also denied our request for reimbursement
of our legal fees associated with the case. The Company filed a notice of appeal as to this
portion of the courts decision.
On February 3, 2005, the Appellate Court reaffirmed the unanimous jury verdict that ISCOs US
patent is invalid and unenforceable. The Appellate Court also denied the Companys request to
reinstate the jurys $3.8 million damage award to us for unfair competition and bad faith on the
part of ISCO. The trial judge had overruled the jurys finding on this point, and the Company
appealed that portion of the judges ruling.
14
Litigation expenses on the ISCO matter totaled $227,000 and $45,000 for the three month
periods ended April 3, 2004 and April 2, 2005, respectively. The Company does not expect any
further legal action related to this matter.
Class Action Lawsuits
The Company and certain of its officers were named as a defendant in several substantially
identical class action lawsuits filed in the United States District Court for the Central District
of California in April 2004. The cases were consolidated in August 2004, and the plaintiffs filed
an amended consolidated complaint in October 2004. The plaintiffs allege securities law violations
by us and certain of our officers and directors under Rule 10b-5 and Sections 10(b) and 20(a) of
the Securities Exchange Act of 1934, as amended. The complaint was filed on behalf of a purported
class of people who purchased our stock during the period between January 9, 2004 and March 1, 2004
and seeks unspecified damages. The plaintiffs base their allegations primarily on the fact that
the Company did not achieve its forecasted revenue guidance of $10 to $13 million for the first
quarter of 2004.
In February 2005 the Company settled with the lead plaintiffs appointed by the District Court
to handle this matter. Under the terms of the settlement, the Companys insurers will pay $4.0
million into a settlement fund, and the Company will pay up to $50,000 of the costs of providing
notice of the settlement to settlement class members. The settlement remains subject to approval
by the District Court. The Company recorded a liability in its December 31, 2004 consolidated
financial statements for the proposed amount of the settlement of $4,050,000. Because the insurance
carrier involved in this suit agreed to pay $4.0 million of the settlement amount, and therefore
recovery from the insurance carrier was probable, a receivable was also recorded for that amount.
These amounts were paid into the settlement fund in April 2005.
Litigation expenses on this matter totaled $216,000 for the three months ended April 2, 2005.
No expenses were incurred in the corresponding period of the prior year.
7. Earnings Per Share
The computation of per share amounts for the three month periods ended April 3, 2004 and April
2, 2005 is based on the average number of common shares outstanding for the period. Options and
warrants to purchase 15,252,999 and 16,316,010 shares of common stock during the three months
periods ended April 3, 2004 and April 2, 2005, respectively, were not considered in the computation
of diluted earnings per share because their inclusion would be anti-dilutive.
8. Commitments and Contingencies
Operating Leases
The Company leases its offices and production facilities under non-cancelable operating leases
that expire at various times over the next seven years. Generally, these leases contain escalation
clauses for increases in annual renewal options and require the Company to pay utilities,
insurance, taxes and other operating expenses.
For the three months ended April 3, 2004, and April 2, 2005, rent expense was $311,000 and
$296,000, respectively.
Capital Leases
The Company leases certain property and equipment under capital lease arrangements that expire
at various dates through 2007. The leases bear interest at various rates ranging from 8.56% to
14.95%.
Patents and Licenses
The Company has entered into various licensing agreements requiring royalty payments ranging
from 0.13% to 2.5% of specified product sales. Certain of these agreements contain provisions for
the payment of guaranteed or minimum royalty amounts. In the event that the Company fails to pay
minimum annual royalties, these licenses may automatically become non-exclusive or be terminated.
These royalty obligations terminate in 2009 to 2020. For the three months ended April 3, 2004 and
April 2, 2005, royalty expense totaled $159,000 and $48,000, respectively. Under the terms of
certain royalty agreements, royalty payments made may be subject to audit. There have been no
audits to date and the Company does not expect any possible future audit adjustments to be
significant.
The minimum lease payments under operating and capital leases and license obligations are as
follows:
15
In connection with the acquisition of Conductus, Inc. as of December 31, 2002 operating leases
with remaining commitments totaling $2,044,000 and $1,758,000 have been abandoned or are considered
unfavorable, respectively. A liability totaling $1,995,000 representing the present value of the
minimum lease payments and executory costs was recorded at December 18, 2002 relating to the
abandoned leases. A liability totaling $1,140,000 representing the present value of the difference
between the fair market rental and lease commitment was recorded at December 31, 2002 relating to
unfavorable leases. In 2004, the Company completed closure of its Sunnyvale facility. A liability
totaling $279,000 was recognized representing the present value of the remainder of the lease
commitment was recorded. In connection with the closure of this facility, the remaining
unfavorable lease commitment of $558,000 recorded in connection with the acquisition of Conductus,
Inc. was transferred to lease abandonment costs. As of April 2, 2005, the remaining minimum lease
commitments on these operating leases totaled $1,071,000 and are included in the above commitment
table. At April 2, 2005, the present value of the remaining liability related to the abandoned
leases totaled $1,041,000. These amounts are included in accrued liabilities.
9 Contractual Guarantees and Indemnities
Warranties
The Company establishes reserves for future product warranty costs that are expected to be
incurred pursuant to specific warranty provisions with its customers. The Companys warranty
reserves are established at the time of sale and updated throughout the warranty period based upon
numerous factors including historical warranty return rates and expenses over various warranty
periods.
During its normal course of business, the Company makes certain contractual guarantees and
indemnities pursuant to which the Company may be required to make future payments under specific
circumstances. The Company has not recorded any liability for these contractual guarantees and
indemnities in the accompanying consolidated financial statements.
A description of significant contractual guarantees and indemnities existing as of April 2,
2005 is included below.
Intellectual Property Indemnities
The Company indemnifies certain customers and its contract manufacturers against liability
arising from third-party claims of intellectual property rights infringement related to the
Companys products. These indemnities appear in development and supply agreements with our
customers as well as manufacturing service agreements with our contract manufacturers, are not
limited in amount or duration and generally survive the expiration of the contract. Given that the
amount of any potential liabilities related to such indemnities cannot be determined until an
infringement claim has been made, the Company is unable to determine the maximum amount of losses
that it could incur related to such indemnifications.
Director and Officer Indemnities and Contractual Guarantees
16
The Company has entered into indemnification agreements with its directors and executive
officers which require the Company to indemnify such individuals to the fullest extent permitted by
Delaware law. The Companys indemnification obligations under such agreements are not limited in
amount or duration. Certain costs incurred in connection with such indemnifications may be
recovered under certain circumstances under various insurance policies. Given that the amount of
any potential liabilities related to such indemnities cannot be determined until a lawsuit has been
filed against a director or executive officer, the Company is unable to determine the maximum
amount of losses that it could incur relating to such indemnifications. Historically, any amounts
payable pursuant to such director and officer indemnifications have not had a material negative
effect on the Companys business, financial condition or results of operations.
The Company has also entered into severance and change in control agreements with certain of
its executives. These agreements provide for the payment of specific compensation benefits to such
executives upon the termination of their employment with the Company.
General Contractual Indemnities/Products Liability
In connection with the sales of its commercial products, the Company indemnifies, without
limit or term, its customers against all claims, suits, demands, damages, liabilities, expenses,
judgments, settlements and penalties arising from actual or alleged infringement or
misappropriation of any intellectual property relating to its products or other claims arising from
its products. The Company cannot reasonably develop an estimate of the maximum potential amount of
payments that might be made under its guarantee because of the uncertainty as to whether a claim
might arise and how much it might total.
Short Term Borrowings
Advances under the agreement are collateralized by all the Companys assets. Under the terms
of the agreement, the Company continues to service the sold receivables and is subject to recourse
provisions. Under the terms of the agreement, if the bank determines that there is a material
adverse change in the Companys business, they can exercise all their rights and remedies under the
agreement.
10. Restructuring Expenses
During 2004, the Company implemented several restructuring programs to streamline its
operations and reduce its cost structure. During the three months ended April 2, 2005, the Company
implemented another restructuring program and reduced its workforce by another 26 positions.
A summary of the restructuring charges for the quarter ended April 2, 2005 is as follows:
11. Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow
Information and Non-Cash Activities
17
Balance Sheet Data
:
At December 31, 2004 and April 2, 2005, equipment includes $237,000 of assets
financed under capital lease arrangements, net of $163,000 and $181,000 of
accumulated amortization, respectively. Depreciation expense amounted to $662,000
and $655,000 for the three month periods ended April 3, 2004 and April 2, 2005,
respectively. Depreciation expense is expected to total $2.0 million for the
remainder of 2005, $2.3 million, $2.0 million, $1.4 million and $1.0 million in each
of the years 2006, 2007, 2008, and 2009, respectively.
Amortization expense related to these items totaled $189,000 and
$82,000 for the three month periods ended April 3, 2004 and April 2,
2005, respectively. Amortization expenses are expected to total
$252,000 for the remainder of 2005, $344,000 in 2006 and $350,000 in
each of the years 2007, 2008 and 2009.
18
19
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
General
We develop, manufacture and market high performance products used with cellular base stations
to maximize the performance of wireless telecommunications networks by improving the quality of
uplink signals from mobile wireless devices. Our solutions leverage our expertise in
high-temperature superconducting (HTS) filters to hear wireless devices with the best possible
clarity while rejecting interfering signals. We believe that this combination of interference
rejection and receiver sensitivity is only possible using HTS technology. We sell our products
directly to wireless carriers in the Americas, and we have plans to expand internationally. Our
customers to date include ALLTEL, AT&T Wireless (now part of Cingular), Sprint, U.S. Cellular, and
Verizon Wireless.
We derive our commercial revenues from three product lines:
SuperLink
. In order to receive uplink signals from wireless handsets, base stations
require a wireless filter system to eliminate, or filter out, out-of-band interference. To address
this need, we offer the SuperLink product line for the receiver front-end of base stations. These
products combine specialized filters using HTS technology with a proprietary cryogenic cooler and a
cooled low-noise amplifier. The result is a highly compact and reliable receiver front-end that
can simultaneously deliver both high selectivity (interference rejection) and high sensitivity
(detection of low level signals). SuperLink products thereby offer significant advantages over
conventional filter systems.
AmpLink
. The recently introduced AmpLink is our lower-cost receiver front-end
product designed specifically to address the sensitivity requirements of wireless base stations.
The AmpLink is a ground-mounted unit which includes a high-performance amplifier and up to six dual
duplexers. The enhanced uplink provided by AmpLink 1900 improves PCS network coverage immediately
and avoids the installation and maintenance costs associated with tower mounted amplifiers. As
network interference increases, the AmpLink 1900 is easily upgradeable to include a SuperLink
front-end, which uses HTS technology to maintain the same sensitivity improvement while eliminating
the effects of increasing interference.
SuperPlex
. SuperPlex, our antenna sharing solution, is a line of multiplexers that
provides extremely low insertion loss and excellent cross-band isolation. Products in our
SuperPlex line of high-performance multiplexers are designed to eliminate the need for additional
base station antennas and reduce infrastructure costs. Relative to competing technologies, these
products offer increased transmit power delivered to the base station antenna, higher sensitivity
to subscriber handset signals, fast and cost-effective network overlays. The SuperPlex product
family offers network performance benefits synergistic with SuperLink.
We began commercial production of the SuperFilter (the precursor to the SuperLink) in 1997.
Our initial commercial sales of our SuperLink products were to small rural providers who had the
most immediate need for range extension and coverage enhancement. We sold our first systems in the
fourth quarter of 1997. In 2004, Verizon Wireless and ALLTEL accounted for 87% of our net
commercial revenues. In the three months ended April 2, 2005, Verizon Wireless and ALLTEL accounted
for 87% of our commercial revenues.
In our business model, we use government contracts as a source of funds for our commercial
technology development. We primarily pursue government research and development contracts which
compliment our commercial product development. In other words, we undertake government contract
work which has the potential to add to or improve our commercial product line. These contracts
often yield valuable intellectual property relevant to our commercial business. We typically own
the intellectual property developed under these contracts, and the Federal Government receives a
royalty-free, non-exclusive and nontransferable license to use the intellectual property for the
United States.
Critical Accounting Policies and Estimates
Our discussion and analysis of our financial condition and results of operations are based
upon our financial statements, which have been prepared in accordance with accounting principles
generally accepted in the United States. The preparation of these financial statements requires us
to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues
and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis,
we evaluate our estimates, including those related to bad debts, inventories, recovery of goodwill
and long-lived assets, including intangible assets, income taxes, warranty obligations, and
contingencies. We base our estimates on historical experience and on various other assumptions
that we believed to be reasonable under the circumstances, the results of which form the basis for
making judgments about the carrying values of assets and liabilities that are not readily apparent
from other sources. Actual results may differ from these estimates under different assumptions or
conditions.
20
We believe the following critical accounting policies affect our more significant judgments
and estimates used in the preparation of the financial statements. We maintain allowances for
doubtful accounts for estimated losses resulting from the inability of our customers to make
required payments. If the financial condition of our customers were to deteriorate, resulting in
an impairment of their ability to make payments, additional allowances may be required. We write
down our inventory for estimated obsolescence or unmarketable inventory equal to the difference
between the cost of inventory and the estimated market value based upon assumptions about future
demand and market conditions. If actual market conditions are less favorable than those projected
by management, additional inventory write-downs may be required.
Our inventory is valued at the lower of its actual cost or the current estimated market value
of the inventory. We review inventory quantities on hand and on order and record a provision for
excess and obsolete inventory and/or vendor cancellation charges related to purchase commitments.
Such provisions are established based on historical usage, adjusted for known changes in demands
for such products, or the estimated forecast of product demand and production requirements. Our
business is characterized by rapid technological change, frequent new product development and rapid
product obsolescence that could result in an increase in the amount of obsolete inventory
quantities on hand. As demonstrated in the past three years, demand for our products can fluctuate
significantly. Our estimates of future product demand may prove to be inaccurate and we may
understate or overstate the provision required for excess and obsolete inventory.
Our net sales consist of revenue from sales of products net of trade discounts and allowances.
We recognize revenue when evidence of an arrangement exists, contractual obligations have been
satisfied, title and risk of loss have been transferred to the customer and collection of the
resulting receivable is reasonably assured. At the time revenue is recognized, we provide for the
estimated cost of product warranties if allowed for under contractual arrangements. Our warranty
obligation is effected by product failure rates and service delivery costs incurred in correcting a
product failure. Should such failure rates or costs differ from these estimates, accrued warranty
costs would be adjusted.
In connection with the sales of its commercial products, the Company indemnifies, without
limit or term, its customers against all claims, suits, demands, damages, liabilities, expenses,
judgments, settlements and penalties arising from actual or alleged infringement or
misappropriation of any intellectual property relating to its products or other claims arising from
its products. The Company cannot reasonably develop an estimate of the maximum potential amount of
payments that might be made under its guarantee because of the uncertainty as to whether a claim
might arise and how much it might total.
Contract revenues are principally generated under research and development contracts.
Contract revenues are recognized utilizing the percentage-of-completion method measured by the
relationship of costs incurred to total estimated contract costs. If the current contract estimate
were to indicate a loss, utilizing the funded amount of the contract, a provision would be made for
the total anticipated loss. Revenues from research related activities are derived primarily from
contracts with agencies of the United States Government. Credit risk related to accounts
receivable arising from such contracts is considered minimal. These contracts include cost-plus,
fixed price and cost sharing arrangements and are generally short-term in nature.
All payments to us for work performed on contracts with agencies of the U.S. Government are
subject to adjustment upon audit by the Defense Contract Audit Agency. Based on historical
experience and review of current projects in process, we believe that the audits will not have a
significant effect on our financial position, results of operations or cash flows. The Defense
Contract Audit Agency has audited us through 2002.
In connection with the acquisition of Conductus we recognized $20 million of goodwill.
Goodwill is tested for impairment annually in the fourth quarter after the annual planning process,
or earlier if events occur which require an impairment analysis be performed. We operate in a
single business segment as a single reporting unit. The first step of the impairment test, used to
identify potential impairment, compares the fair value based on market capitalization of the entire
Company with the book value of its net assets, including goodwill. The Companys market
capitalization is based the closing price of our common stock as traded on NASDAQ multiplied by our
outstanding common shares. If the fair value of the Company exceeds the book value of our net
assets, our goodwill is not considered impaired. If the book value of our net assets exceeds our
fair value, the second step of the goodwill impairment test shall be performed to measure the
amount of impairment loss. The second step of the goodwill impairment test, used to measure the
amount of impairment loss, compares the implied fair value of the goodwill with the book value of
that goodwill. If the carrying amount of the reporting unit goodwill exceeds the implied fair
value of that goodwill, an impairment loss shall be recognized in an amount equal to that excess.
At December 31, 2004, we tested the goodwill for possible impairment and determined that there was
no impairment. The fair value of the Company based on its market capitalization totaled $149.7
million which was in excess of the total book value of the Company. Therefore, our goodwill was
not considered impaired. This goodwill will again be tested for impairment in the fourth quarter
of 2005 or earlier if events occur which require an earlier assessment. If the carrying amount
exceeds its implied fair value, an impairment loss will be recognized equal to the excess. At April
2, 2005, the fair value of the Company based on its market capitalization had declined to $73.2
million, which is in excess of the total book value of the Company. If the market capitalization of
the Company declines below the Companys book value of its net assets before the next annual
goodwill impairment test, and it is determined that the decline is other than temporary, then an
impairment loss relating to the goodwill will be recognized for the amount of its carrying amount
in excess of its implied fair value. Any future impairment of our
21
goodwill could have a material adverse effect on our financial position and results of
operations.
We periodically evaluate the realizability of long-lived assets as events or circumstances
indicate a possible inability to recover the carrying amount. Long-lived assets that will no
longer be used in business are written off in the period identified since they will no longer
generate any positive cash flows for the Company. Periodically, long-lived assets that will
continue to be used by the Company need to be evaluated for recoverability. Such evaluation is
based on various analyses, including cash flow and profitability projections. The analyses
necessarily involve significant management judgment. In the event the projected undiscounted cash
flows are less than net book value of the assets, the carrying value of the assets will be written
down to their estimated fair value. We completed such an analysis as of the fourth quarter of 2004
and determined that no write down was necessary. Our estimates of future cash flows may prove to
be inaccurate, and we may understate or overstate the write down of long lived assets. During the
first quarter of 2005, the market capitalization of the Company declined. If the market
capitalization of the Company declines below the Companys book value, and it is deemed other than
temporary, then an impairment loss relating to the Companys long lived assets might be recognized.
Any future impairment of our long-lived assets could have a material adverse effect on our
financial position and results of operations.
As permitted under Statement of Financial Accounting Standards No. 123 (SFAS 123), Accounting
for Stock-Based Compensation, we have elected to follow Accounting Principles Board Opinion No.
25, Accounting for Stock Issued to Employees in accounting for its stock options and other
stock-based employee awards. Pro forma information regarding net loss and loss per share, as
calculated under the provisions of SFAS 123, are disclosed in the notes to the financial
statements. We account for equity securities issued to non-employees in accordance with the
provision of SFAS 123 and Emerging Issues Task Force 96-18.
If we had elected to recognize compensation expense for employee awards based upon the fair
value at the grant date consistent with the methodology prescribed by SFAS 123, our net loss and
net loss per share would have been increased to the pro forma amounts indicated below:
Our valuation allowance against the deferred tax assets is based on our assessments of
historical losses and projected operating results in future periods. If and when we generate
future taxable income in the U.S. against which these tax assets may be applied, some portion or
all of the valuation allowance would be reversed and an increase in net income would consequently
be reported in future years.
We are currently involved as a defendant in a securities class action lawsuit. This matter is
discussed below in
Legal Proceedings
. In February 2005 we settled with the lead plaintiffs
appointed by the District Court to handle this matter. Under the terms of the settlement, the
Companys insurers will pay $4.0 million into a settlement fund, and the Company will pay up to
$50,000 of the costs of providing notice of the settlement to settlement class members. The
settlement remains subject to approval by the District Court. We recorded a liability in its
December 31, 2004 consolidated financial statements for the proposed amount of the settlement of
$4,050,000. Because the insurance carrier involved in this suit agreed to pay $4.0 million of the
settlement amount, and therefore recovery from the insurance carrier was probable, a receivable was
also recorded for that amount. These amounts were paid into the settlement fund in April 2005. We
periodically reassess our potential liability as additional information becomes available. If we
later determine that the probable loss is greater than our reserve or expected insurance proceeds,
we would record an additional reserve for the potential additional loss. The ultimate amount of
further losses, if any, could materially impact our results of operations, financial condition or
cash flows.
Backlog
Our commercial backlog consists of accepted product purchase orders with scheduled delivery
dates during the next twelve months. We had commercial backlog of $5.1 million at April 2, 2005,
as compared to $730,000 at December 31, 2004.
22
We also had at April 2, 2005 remaining minimum purchase commitments totaling $5.3 million from
one customer under a general purchase agreement. We expect to fulfill these commitments during
2005, but we did not include them in our backlog because the customer has not identified the
product mix and/or scheduled delivery dates.
Results of Operations
Quarter Ended April 2, 2005 as compared to the Quarter Ended April 3, 2004
Net revenues decreased by $1.0 million, or 20%, from $5.4 million in the first quarter of 2004
to $4.4 million in the first quarter of 2005. Net revenues consist primarily of commercial product
revenues and government contract revenues. We also generate some additional revenues from
sublicensing our technology.
Net commercial product revenues increased to $3.8 million in the first quarter of 2005 from
$3.2 million in the first quarter of 2004, an increase of $585,000, or 18%. The increase is
primarily the result of a higher sales of our SuperPlex multiplexers and AmpLink products,
partially offset by decreased sales of our SuperLink product due to lower average selling prices.
Our two largest customers accounted for 87% of our net commercial revenues in the first quarter of
2005, which is comparable to the first quarter in 2004. These customers generally purchase
products through non-binding commitments with minimal lead-times. Consequently, our commercial
product revenues can fluctuate dramatically from quarter to quarter based on changes in our
customers capital spending patterns.
Government contract revenues decreased to $571,000 in the first quarter of 2005 from $2.2
million in the first quarter of 2004, a decrease of $1.7 million, or 75%. This decrease is
primarily attributable to the completion of contracts in 2004 that have not been replaced.
Cost of commercial product revenues includes all direct costs, manufacturing overhead,
provision for excess and obsolete inventories and restructuring and impairment charges relating to
the manufacturing operations. The cost of commercial product revenue totaled $4.2 million for the
first quarter of 2005 compared to $3.8 million for the first quarter of 2004, an increase of
$416,000, or 11%. Increased costs result primarily from increased units shipments and changes in
overhead absorption. Our cost of sales includes both variable and fixed cost components. The
variable component consists primarily of materials, assembly and test labor, overhead, which
includes equipment and facility depreciation, transportation costs and warranty costs. The fixed
component includes test equipment and facility depreciation, purchasing and procurement expenses
and quality assurance costs. Given the fixed nature of such costs, the absorption of our
production overhead costs into inventory decreases and the amount of production overhead variances
expensed to cost of sales increases as production volumes decline since we have fewer units to
absorb our overhead costs against. Conversely, the absorption of our production overhead costs
into inventory increases and the amount of production overhead variances expensed to cost of sales
decreases as production volumes increase since we have more units to absorb our overhead costs
against. As a result, our gross profit margins generally decrease as revenue and production
volumes decline due to lower sales volume and higher amounts of production overhead variances
expensed to cost of sales; and our gross profit margins generally increase as our revenue and
production volumes increase due to higher sales volume and lower amounts of production overhead
variances expensed to cost of sales.
The following is an analysis of our commercial product gross profit and margins:
We had a negative gross profit of $431,000 in the first quarter of 2005 from the sale of our
commercial products as compared to a negative gross profit of $600,000 in the first quarter of
2004. We experienced negative gross profits in the first quarters of 2004 and 2005 because the
reduced level of commercial sales was insufficient to cover our fixed manufacturing overhead costs.
Our gross margins were also impacted by charges for excess and obsolete inventory of
approximately $90,000 in the first quarter of 2005 and 2004. We regularly review inventory
quantities on hand and provided an allowance for excess and obsolete inventory based on numerous
factors including sales backlog, historical inventory usage, forecasted product demand and
production requirements for the next twelve months. Gross margins in the first quarter of 2005 were
favorably impacted by lower manufacturing overhead expenses resulting from our restructuring
efforts.
Contract research and development expenses totaled $683,000 in the first quarter of 2005 as
compared to $1.5 million in the first quarter of 2004. These decreases were the result of lower
expenses associated with performing a fewer number of government contracts offset by higher
expenses associated with completing two contracts.
23
Other research and development expenses relate to development of new wireless commercial
products. We also incur design expenses associated with reducing the cost and improving the
manufacturability of our existing products. These expenses totaled $1.2 million in the first
quarter of 2005 as compared to $1.3 million in the same quarter of the prior year. The decrease is
due to reduced commercial products development and cost reduction efforts.
Selling, general and administrative expenses totaled $3.8 million in the first quarter of
2005, as compared to $4.6 million in the first quarter of the prior year. The decrease from 2004
results primarily from lower ISCO litigation expenses, the closure of our Sunnyvale facility and
lower expenses resulting from restructuring activities. These decreases were partially offset by
higher legal expenses associated with the class action lawsuit and higher expenses related to the
retirement benefits to be paid to our former President and Chief Executive Officer.
During 2004, we implemented several restructuring programs to streamline our operations and
reduce our cost structure. We consolidated our Sunnyvale operations into our Santa Barbara
facility and reduced our total workforce. The workforce reduction included reductions associated
with the Sunnyvale consolidation, as well as other strategic reductions in the organization. In
addition, as part of the consolidation, we accelerated a program to implement of a new, lower cost
wafer deposition process called Reactive Co-Evaporation.
During the three months ended April 2, 2005, the Company implemented another restructuring
program and reduced its workforce by another 26 positions.
The following table summarizes our actual restructuring charges for the first quarter of 2005
and our estimated charges for the remainder of 2005 relating to the actions taken in 2004 and the
first quarter of 2005:
Interest income increased in the first quarter of 2005, as compared to the prior year,
primarily because we had more cash available for investment.
Interest expense in the first quarter of 2005 decreased to $39,000, as compared to the prior
year, because of lower borrowings.
We had a net loss of $5.5 million for the quarter ended April 2, 2005, as compared to $5.9
million in the same period last year.
The net loss available to common shareholders totaled $0.05 per common share in the first
quarter of 2005, as compared to $0.09 per common share in the same period last year.
Liquidity and Capital Resources
Cash Flow Analysis
As of April 2, 2005, we had working capital of $11.2 million, including $7.5 million in cash
and cash equivalents, as compared to working capital of $16.1 million at December 31, 2004, which
included $12.8 million in cash and cash equivalents. We currently invest our excess cash in
short-term, investment-grade, money-market instruments with maturities of three months or less. We
believe that all of our cash investments would be readily available to us should the need arise.
Cash and cash equivalents decreased by $5.3 million from $12.8 million at December 31, 2004 to
$7.5 million at April 2, 2005. Cash was used in operations, for the purchase of property and
equipment, for the payment of short and long-term borrowings and for the payment of common stock
offering expenses. These uses were partially offset by cash proceeds received
24
from new borrowings on our line of credit. Cash and cash equivalents decreased by $7.2
million to $3.9 million in the three month period ended April 3, 2004. Cash was used in
operations, the purchase of property and equipment payment of short and long-term borrowings.
These uses were partially offset by cash proceeds received from new borrowings on our line of
credit and cash proceeds from the exercise of options and warrants.
Cash used in operations totaled $4.2 million in the first quarter of 2005. We used $4.6
million to fund the cash portion of our net loss. We also used cash to fund a $247,000 increases
in other assets and accounts payable payments. These uses were offset by cash generated from the
collection of accounts receivable and lower inventory and prepaid balances totaling $605,000. Cash
used in operations totaled $3.9 million in the first quarter of 2004. We used $5.0 million to fund
the cash portion of our net loss. We also used cash to fund a $5.2 million increase in inventory,
patents and licenses and other assets and accounts payable payments. Inventory increased in the
first quarter of 2004 due to lower than expected sales. These uses were partially offset by cash
generated from the collection of accounts receivable and from the decline in other assets which
totaled $6.3 million.
Net cash used in investing activities totaled $33,000 in the first quarter of 2005 as compared
to $1.1 million in the first quarter of last year. These expenditures related primarily to
purchases of manufacturing equipment and facilities improvements to increase our production
capacity.
Net cash used in financing activities totaled $1.1 million in the first quarter of 2005. Cash
used to pay down our line of credit and long term debt totaled $294,000. Cash was also used to pay
$797,000 of offering expenses related to the sale of common stock in November 2004. Net cash used
in financing activities totaled $2.2 million in the first quarter of 2004. Net payments against our
line of credit and payment against our long-term debt totaled $2.7 million. This was partially
offset by cash received from the exercise of warrants and options.
Financing Activities
We have historically financed our operations through a combination of cash on hand, cash
provided from operations, equipment lease financings, available borrowings under bank lines of
credit and both private and public equity offerings. We have effective registration statements on
file with the SEC covering the public resale by investors of all the common stock issued in our
private placements, as well as any common stock acquired upon exercise of their warrants.
We have an existing line of credit from a bank. It is a material source of funds for our
business. The line of credit expires June 15, 2006 The loan agreement is structured as a sale of
our accounts receivable and provides for the sale of up to $5.0 million of eligible accounts
receivable, with advances to us totaling 80% of the receivables sold. Advances bear interest at
the prime rate (5.75% at April 2, 2005) plus 2.50% subject to a minimum monthly charge.
Outstanding amounts under this borrowing facility at April 2, 2005 totaled $662,000. The amount
outstanding is repaid upon collection of the underlying accounts receivable. Advances are
collateralized by a lien on all of our assets. Under the terms of the agreement, we continue to
service the sold receivables and are subject to recourse provisions.
Contractual Obligations and Commercial Commitments
We incur various contractual obligations and commercial commitments in our normal course of
business. They consist of the following:
Our capital lease obligations are for property and equipment and total $70,000 at April 2, 2005.
Our operating lease obligations consist of facility leases in Santa Barbara and Sunnyvale,
California. We assumed the Sunnyvale leases in connection with our acquisition of Conductus, Inc.
in 2002. At April 2, 2005, the remaining Sunnyvale lease obligations totaled $1.1 million and are
due in monthly installments through February 2006. We consolidated the Sunnyvale operations into
our Santa Barbara facility in 2004 and recorded a liability for the present value of the remaining
obligations under the Sunnyvale leases. We included these liabilities in the financial statements
under Accrued Liabilities and Other Long Term Liabilities.
We have entered into various licensing agreements requiring royalty payments ranging from
0.13% to 2.5% of specified product sales. Some of these agreements contain provisions for the
payment of guaranteed or minimum royalty amounts. Typically, the licensor can terminate our
license if we fail to pay minimum annual royalties.
In the normal course of business, we incur purchase obligations with vendors and suppliers for
the purchase of inventory, as well as other goods and services. These obligations are generally
evidenced by purchase orders that contain the
25
terms and conditions associated with the purchase arrangements. We are committed to accept
delivery of such material pursuant to the purchase orders subject to various contract provisions
which allow us to delay receipt of such orders or cancel orders beyond certain agreed upon lead
times. Cancellations may result in cancellation costs payable by us.
At April 2, 2005, we had the following contractual obligations and commercial commitments:
Capital Expenditures
We plan to invest approximately $450,000 in fixed assets during the remainder of 2005.
Future Liquidity
Our principal sources of liquidity consist of existing cash balances and funds expected to be
generated from future operations. We believe our existing cash resources, together with our line
of credit and a planned inventory reduction, will be sufficient to fund our planned operations for
at least the next twelve months. We have more inventory than required for current sales volumes
and plan to use our excess inventory as a material source of funding in 2005. We believe the key
factors to our liquidity in 2005 will be our ability to successfully execute on our plans to
increase sales levels and to convert excess inventory to cash. There is no assurance that the
Company will be able to increase sales levels or to sell excess inventory, Our cash requirements
will also depend on numerous other variable factors, including the rate of growth of sales, the
timing and levels of products purchased, payment terms and credit limits from manufacturers, and
the timing and level of accounts receivable collections.
If actual cash flows deviate significantly from forecasted amounts, we may require additional
financing in the next twelve months. We cannot assure you that additional financing (public or
private) will be available on acceptable terms or at all. If we issue additional equity securities
to raise funds, the ownership percentage of our existing stockholders would be reduced. New
investors may demand rights, preferences or privileges senior to those of existing holders of
common stock. If we cannot raise any needed funds, we might be forced to make further substantial
reductions in our operating expenses, which could adversely affect our ability to implement our
current business plan and ultimately our viability as a company.
In the last several years, we have raised money from investors to cover our operating losses
through public and private offerings. Our ability to continue to raise funds using these methods
may be adversely impacted by NASDAQ listing issues. Our continued NASDAQ listing requires us to
maintain a minimum stock price of $1 per share. Our stock traded below $1 per share for 30
consecutive business days prior to April 4, 2005. We received a notice of potential delisting from
the Nasdaq Stock Market on that date and have been provided until October 3, 2005 to regain
compliance with the NASDAQ minimum price rule. If we cannot demonstrate compliance with the
minimum price rule by that date, we may request a transfer to the Nasdaq SmallCap Market (presuming
we continue to meet the initial listing criteria except for the minimum price requirement) and
secure an additional 180 calendar day compliance period which is typically provided to SmallCap
issuers. In order to maximize our options for addressing this problem, we are submitting a request
to our stockholders at the 2005 annual meeting for discretionary authority over the next year to
implement a reverse stock split in the range of 1-for-2 to 1-for-10. The annual meeting is
scheduled for May 25, 2005, and we have mailed our proxy statement to the stockholders.
Our financial statements have been prepared assuming that the Company will continue as a going
concern. The factors described above raise substantial doubt about our ability to continue as a
going concern. Our financial statements do not include any adjustments that might result from this
uncertainty.
Our independent registered public accounting firm has included in their audit report for
fiscal 2004 an explanatory paragraph expressing doubt about our ability to continue as a going
concern. They included a similar explanatory paragraph in their audit report for 2002 and 2003.
In 2004, we incurred a net loss of $31.2 million and had negative cash flows from operations of
$21.6 million. In response, we reduced direct and indirect labor and continued to cut fixed costs.
We also
26
consolidated our Sunnyvale operations into our Santa Barbara facility and accelerated the
implementation of a new, lower cost wafer deposition process. In the first quarter of 2005 we
incurred a net loss of $5.5 million and had negative cash flows from operations of $4.2 million.
We are continuing to look for opportunities to reduce expenses and generate cash.
Net Operating Loss Carryforward
As of December 31, 2004, we had net operating loss carryforwards for federal and state income
tax purposes of approximately $244.6 million and $119.4 million, respectively, which expire in the
years 2005 through 2024. Of these amounts $93.7 million and $30.2 million, respectively resulted
from the acquisition of Conductus. Included in the net operating loss carryforwards are deductions
related to stock options of approximately $24.1 million and $13.1 million for federal and
California income tax purposes, respectively. To the extent net operating loss carryforwards are
recognized for accounting purposes the resulting benefits related to the stock options will be
credited to stockholders equity. In addition, we have research and development and other tax
credits for federal and state income tax purposes of approximately $2.6 million and $2.4 million,
respectively, which expire in the years 2005 through 2024. Of these amounts $972,000 and $736,000,
respectively resulted from the acquisition of Conductus.
Due to the uncertainty surrounding their realization, we have recorded a full valuation
allowance against our net deferred tax assets. Accordingly, no deferred tax asset has been
recorded in the accompanying balance sheet.
Section 382 of the Internal Revenue Code imposes an annual limitation on the utilization of
net operating loss carryforwards based on a statutory rate of return (usually the applicable
federal funds rate, as defined in the Internal Revenue Code) and the value of the corporation at
the time of a change of ownership as defined by Section 382. We completed an analysis of our
equity transactions and determined that we had a change in ownership in August 1999 and December
2002. Therefore, the ability to utilize net operating loss carryforwards incurred prior to the
change of ownership totaling $101.6 million will be subject in future periods to an annual
limitation of $1.3 million. In addition, we acquired the right to Conductus net operating losses,
which are also subject to the limitations imposed by Section 382. Conductus underwent three
ownership changes, which occurred in February 1999, February 2001 and December 2002. Therefore,
the ability to utilize Conductus net operating loss carryforwards of $93.7 million incurred prior
to the ownership changes will be subject in future periods to annual limitation of $700,000. Net
operating losses incurred by us subsequent to the ownership changes totaled $51.4 million and are
not subject to this limitation.
Future Accounting Requirements
In
December 2004, the Financial Accounting Standards Board issued
SFAS No. 123(R) (revised
2004), Share-Based Payment which amends SFAS Statement 123 and will be effective for public
companies for annual periods beginning after June 15, 2005. The new standard will require us to
recognize compensation costs in our financial statements in an amount equal to the fair value of
share-based payments granted to employees and directors. We are currently evaluating how we will
adopt the standard and evaluating the effect that the adoption of
SFAS 123(R) will have on our
financial position and results of operations
In November 2004, the FASB issued SFAS No. 151, Inventory Costs, and amendment of ARB No.
43, Chapter 4. This statement amends the guidance in ARB No. 43, Chapter 4, Inventory Pricing, to
clarify the accounting for abnormal amounts of idle facility expense, freight, handling costs, and
wasted material (spoilage). Paragraph 5 of ARB No. 43, Chapter 4, previously stated that ...under
some circumstances, items such as idle facility expense, excessive spoilage, double freight, and
rehandling costs may be so abnormal as to require treatment as current period charges.... SFAS No.
151 requires that those items be recognized as current-period charges regardless of whether they
meet the criterion of so abnormal. In addition, this statement requires that allocation of fixed
production overheads to the cost of conversion be based on the normal capacity of the production
facilities. The provisions of SFAS 151 shall be applied prospectively and are effective for
inventory costs incurred during fiscal years beginning after June 15, 2005, with earlier
application permitted for inventory costs incurred during fiscal years beginning after the date
this Statement was issued. We do not expect the adoption of SFAS No. 151 to have a material impact
on our financial position and results of operations.
Forward-Looking Statements
This report contains forward-looking statements that involve risks and uncertainties. We have
made these statements in reliance on the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Our forward-looking statements relate to future events or our
future performance and include, but are not limited to, statements concerning our business
strategy, future commercial revenues, market growth, capital requirements, new product
introductions, expansion plans and the adequacy of our funding. Other statements contained in this
report that are not historical facts are also forward-looking statements. We have tried, wherever
possible, to identify forward-looking statements by terminology such as may, will, could,
should, expects, anticipates, intends, plans, believes, seeks, estimates and other
comparable terminology.
27
Forward-looking statements are not guarantees of future performance and are subject to various
risks, uncertainties and assumptions that are difficult to predict. Therefore, actual results may
differ materially from those expressed in forward-looking statements. They can be affected by many
factors, including, but not limited to the following:
Please read the section in our 2004 Annual Report on Form 10-K entitled
Business
Additional Factors That May Affect Our Future Results
for a description of additional
uncertainties and factors that may affect our forward-looking statements. Forward-looking
statements are based on information presently available to senior management, and we do not assume
any duty to update our forward-looking statements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
There was no material change in our exposure to market risk at April 2, 2005 as compared with
our market risk exposure on December 31, 2004. See Managements Discussion and Analysis of
Financial Condition and Results of Operations Market Risk in our 2004 Annual Report on Form
10-K.
Item 4. Disclosure Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are designed to provide reasonable assurance that
information required to be disclosed by us in the reports that we file or submit, is recorded,
processed, summarized and reported, within the time periods specified in the U.S. Securities and
Exchange Commissions rules and forms. Our Chief Executive Officer and Chief Financial Officer
have evaluated our disclosure controls and procedures and have concluded that they were effective
as of April 2, 2005.
Changes in Internal Controls
There has been no change in our internal control over financial reporting (as defined in
Exchange Act Rules 13a-15(f) and 15(d) 15(f)) during the first quarter of 2005 that has
materially affected, or is reasonably likely to materially affect, our internal control over
financial reporting. Because of its inherent limitations, internal control over financial
reporting may not prevent or detect misstatements. Also, projections of any evaluation of
effectiveness to future periods are subject to risk that controls may become inadequate because of
changes in conditions, or that the degree of compliance with the policies or procedures may
deteriorate.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
Patent Litigation
The Company was engaged in a patent dispute with ISCO International, Inc. relating to U.S.
Patent No. 6,263,215 entitled Cryoelectronically Cooled Receiver Front End for Mobile Radio
Systems. ISCO filed a complaint on July 17, 2001 in the United States District Court for the
District of Delaware against us and our wholly-owned subsidiary, Conductus, Inc. The ISCO
complaint alleged that our SuperFilter product and Conductus ClearSite® product infringe ISCOs
patent. The matter went to trial on March 17, 2003.
On April 3, 2003, the jury returned a unanimous verdict that our SuperFilter product does not
infringe the patent in question, and that ISCOs patent is invalid and unenforceable. The jury
also awarded us $3.8 million in compensatory damages based upon a finding that ISCO engaged in
unfair competition and acted in bad faith by issuing press releases and contacting our customers
asserting rights under this patent.
28
On April 17, 2003, the Company filed a Motion for Attorneys Fees and Disbursements, in which
it asked the court to award it its attorneys fees and other litigation expenses. On the same
date, ISCO filed a motion, asking the court to overturn the verdict and grant a new trial. In
August 2003, the court rejected ISCOs request to overturn the jurys verdict that the patent is
invalid and not infringed by the SuperFilter product, and accepted the jurys verdict that the
patent is unenforceable because of inequitable conduct committed by one of the alleged inventors.
ISCO subsequently filed a notice of appeal as to this portion of the courts decision. The court
overturned the jurys verdict of unfair competition and bad faith on the part of ISCO and the
related $3.8 million compensatory damage award to us, and also denied our request for reimbursement
of our legal fees associated with the case. The Company filed a notice of appeal as to this
portion of the courts decision.
On February 3, 2005, the Appellate Court reaffirmed the unanimous jury verdict that ISCOs US
patent is invalid and unenforceable. The Appellate Court also denied the Companys request to
reinstate the jurys $3.8 million damage award to us for unfair competition and bad faith on the
part of ISCO. The trial judge had overruled the jurys finding on this point, and the Company
appealed that portion of the judges ruling.
Class Action Lawsuits
The Company and certain of its officers were named as a defendant in several substantially
identical class action lawsuits filed in the United States District Court for the Central District
of California in April 2004. The cases were consolidated in August 2004, and the plaintiffs filed
an amended consolidated complaint in October 2004. The plaintiffs allege securities law violations
by us and certain of our officers and directors under Rule 10b-5 and Sections 10(b) and 20(a) of
the Securities Exchange Act of 1934, as amended. The complaint was filed on behalf of a purported
class of people who purchased our stock during the period between January 9, 2004 and March 1, 2004
and seeks unspecified damages. The plaintiffs base their allegations primarily on the fact that
the Company did not achieve its forecasted revenue guidance of $10 to $13 million for the first
quarter of 2004.
In February 2005 the Company settled with the lead plaintiffs appointed by the District Court
to handle this matter. Under the terms of the settlement, the Companys insurers will pay $4.0
million into a settlement fund, and the Company will pay up to $50,000 of the costs of providing
notice of the settlement to settlement class members. The settlement remains subject to approval
by the District Court. The Company recorded a liability in its December 31, 2004 consolidated
financial statements for the proposed amount of the settlement of $4,050,000. Because the insurance
carrier involved in this suit agreed to pay $4.0 million of the settlement amount, and therefore
recovery from the insurance carrier was probable, a receivable was also recorded for that amount.
These amounts were paid into the settlement fund in April 2005.
Item 5. Other Information
(a) Additional Disclosures
None
(b) Stockholder Nominations
There have been no material changes to the procedures by which stockholders may recommend
nominees to our board of directors. Please see the discussion of our procedures under the heading
Board Meetings and Committees on pages 4 and 5 of our 2005 Proxy Statement available online at
www.sec.gov
.
Item 6. Exhibits
29
30
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Three Months Ended
April 3, 2004
April 2, 2005
$
3,183,000
$
3,768,000
2,241,000
571,000
20,000
15,000
5,444,000
4,354,000
3,783,000
4,199,000
1,512,000
683,000
1,339,000
1,161,000
4,617,000
3,782,000
84,000
11,251,000
9,909,000
(5,807,000
)
(5,555,000
)
24,000
57,000
(127,000
)
(39,000
)
$
(5,910,000
)
$
(5,537,000
)
$
(0.09
)
$
(0.05
)
69,042,053
107,711,026
Table of Contents
Table of Contents
Three Months Ended
April 3, 2004
April 2, 2005
$
(5,910,000
)
$
(5,537,000
)
869,000
741,000
88,000
90,000
150,000
6,181,000
207,000
(4,663,000
)
318,000
125,000
80,000
(118,000
)
(43,000
)
(23,000
)
(502,000
)
(181,000
)
(3,930,000
)
(4,198,000
)
(1,052,000
)
(33,000
)
(1,052,000
)
(33,000
)
1,188,000
662,000
(3,308,000
)
(938,000
)
(595,000
)
(18,000
)
473,000
(797,000
)
(2,242,000
)
(1,091,000
)
(7,224,000
)
(5,322,000
)
11,144,000
12,802,000
$
3,920,000
$
7,480,000
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Three Months Ended
April 3, 2004
April 2, 2005
$
(5,910,000
)
$
(5,537,000
)
(1,668,000
)
(1,724,000
)
$
(7,578,000
)
$
(7,261,000
)
$
(0.09
)
$
(0.05
)
(0.02
)
(0.02
)
$
(0.11
)
$
(0.07
)
Table of Contents
Table of Contents
Weighted
Weighted
Average
Number of
Average
Number of
Exercise
Options
Exercise
Shares
Price Per Share
Price
Exercisable
Price
9,467,248
$
0.84
$
49.375
$
5.521
5,001,189
$
6.202
1,264,000
$
0.67
$
1.33
$
1.035
(507,751
)
$
1.00
$
35.625
$
4.399
10,223,498
$
0.67
$
49.375
$
5.022
6,863,284
$
6.471
Table of Contents
Common Shares
Total and
Price
Currently
per
Exercisable
Share
Expiration Date
1,217,966
$
18.91
September 29, 2005**
397,857
5.50
March 10, 2007
1,406,581
1.19
December 17, 2007*
1,162,790
2.90
June 24, 2008*
633,562
1.46
April 28, 2011* **
100,000
1.85
April 28, 2011*
72,756
22.383
August 7, 2005
1,095,000
4.583
September 27, 2007
6,000
31.25
September 1, 2007
6,092,512
*
The terms of these warrants contain net exercise provisions, wherein instead of a cash
exercise holders can elect to receive common stock equal to the difference between the
exercise price and the average closing sale price for common shares over 10-30 days
immediately preceding the exercise date.
**
The terms of these warrants contain antidilution adjustment provisions.
Table of Contents
Table of Contents
Operating
Year ending December 31,
Licenses
Leases
Capital Leases
$
150,000
$
1,798,000
$
33,000
150,000
1,406,000
22,000
150,000
1,234,000
15,000
150,000
1,271,000
150,000
1,315,000
1,500,000
2,653,000
$
2,250,000
$
9,677,000
70,000
(12,000
)
58,000
(30,000
)
$
28,000
Table of Contents
Quarter Ended
April 2, 2005
$
118,000
5,000
10,000
$
133,000
(49,000
)
$
84,000
Table of Contents
December 31,
April 2,
2004
2005
$
1,043,000
$
1,005,000
468,000
297,000
(77,000
)
(75,000
)
$
1,434,000
$
1,227,000
December 31,
April 2,
2004
2005
$
3,954,000
$
3,934,000
3,441,000
3,688,000
7,334,000
6,703,000
(5,402,000
)
(5,406,000
)
$
9,327,000
$
8,919,000
December 31,
April 2,
2004
2005
$
18,240,000
$
18,242,000
6,801,000
6,814,000
451,000
451,000
25,492,000
25,507,000
(15,189,000
)
(15,829,000
)
$
10,303,000
$
9,678,000
December 31,
April 2,
2004
2005
$
433,000
$
463,000
899,000
911,000
(203,000
)
(217,000
)
696,000
694,000
563,000
563,000
(33,000
)
(41,000
)
530,000
522,000
1,706,000
1,706,000
(532,000
)
(591,000
)
1,174,000
1,115,000
$
2,833,000
$
2,794,000
Table of Contents
December 31,
April 2,
2004
2005
$
1,285,000
$
1,307,000
419,000
506,000
1,336,000
1,041,000
885,000
764,000
36,000
32,000
1,393,000
563,000
5,354,000
4,213,000
(4,601,000
)
(3,614,000
)
$
753,000
$
599,000
For the three months ended,
April 3,
April 2,
2004
2005
$
494,000
$
419,000
36,000
30,000
(84,000
)
141,000
$
530,000
$
506,000
$
823,000
$
(85,000
)
$
738,000
$
$
1,329,000
$
1,336,000
(192,000
)
(295,000
)
$
1,137,000
$
1,041,000
$
913,000
$
885,000
(36,000
)
(121,000
)
$
877,000
$
764,000
$
285,000
$
36,000
118,000
(266,000
)
(122,000
)
$
19,000
$
32,000
Table of Contents
Table of Contents
Table of Contents
Three Months Ended
April 3, 2004
April 2, 2005
$
(5,910,000
)
$
(5,537,000
)
(1,668,000
)
(1,724,000
)
$
(7,578,,000
)
$
(7,261,000
)
$
(0.09
)
$
(0.05
)
(0.02
)
(0.02
)
$
(0.11
)
$
(0.07
)
Table of Contents
For the quarters ended
April 3, 2004
April 2, 2005
(Dollars in thousands)
$
3,183
100.0
%
$
3,768
100.0
%
3,783
118.9
%
4,199
111.4
%
$
(600
)
(18.9
%)
$
(431
)
(11.4
%)
Table of Contents
Actual
Additional
Restructuring
Charges To Be
Charges for
Incurred In
the First
2005 for Prior
Quarter of
Restructuring
2005
Activities
$
118,000
$
5,000
10,000
40,000
$
133,000
$
40,000
49,000
$
84,000
$
40,000
Table of Contents
Capital Lease Obligations
Operating Lease Obligations
Patents and Licenses
Purchase Commitments
Table of Contents
Quantitative Summary of Contractual Obligations and Commercial Commitments
Payments Due by Period
Contractual Obligations
Total
Less than 1 year
2-3 years
4-5 years
After 5 years
$
70,000
$
38,000
$
32,000
$
$
9,677,000
2,306,000
2,448,000
2,609,000
2,314,000
2,250,000
150,000
300,000
300,000
1,500,000
1,604,000
1,604,000
$
13,601,000
$
4,098,000
$
2,780,000
$
2,909,000
$
3,814,000
Table of Contents
Table of Contents
fluctuations in product demand from quarter to quarter which can be significant,
the impact of competitive filter products, technologies and pricing,
manufacturing capacity constraints and difficulties,
market acceptance risks, and
general economic conditions.
Table of Contents
Number
Description of Document
Amended and Restated Certificate of Incorporation of the Company (1)
Certificate of Amendment of Restated Certificate of Incorporation (2)
Bylaws of the Registrant (3)
Certificate of Amendment of Bylaws dated May 17, 2001 (2)
Certificate of Amendment of Bylaws dated August 8, 2001 (2)
Form of Common Stock Certificate (4)
Third Amended and Restated Stockholders Rights Agreement (3)
Table of Contents
Number
Description of Document
Warrant Issued to PNC Bank, National Association in connection with Credit Agreement
(3)
Registration Rights Agreement to United States Cellular Corporation (5)
Form of Warrant to United States Cellular Corporation (5)
Warrant Purchase Agreement dated December 1, 1999 with PNC Bank (6)
Warrant Purchase Agreement dated January 12, 2000 with PNC Bank (6)
Certificate of Designations, Preferences and Rights of Series E Convertible Stock (7)
Securities Purchase Agreement dated as of September 29, 2000 between the Company and
RGC International Investors, LDC. (Exhibits and Schedules Omitted) (7)
Registration Rights Agreement dated as of September 29, 2000 between the Company and
RGC International Investors, LDC. (7)
Initial Stock Purchase Warrant dated as of September 29, 2000 between the Company
and RGC International Investors, LDC. (7)
Incentive Stock Purchase Warrant dated as of September 29, 2000 between the Company
and RGC International Investors, LDC. (7)
Registration Rights Agreement, dated March 6, 2002 (8)
Warrants to Purchase Shares of Common Stock, dated March 11, 2002 (8)
Registration Rights Agreement dated October 10, 2002 (9)
Warrants to Purchase Common Stock dated October 10, 2002 (9)
Common Stock Purchase Agreement, dated March 8, 2002 between Conductus, Inc. and the
investors signatory thereto (10)
Warrant to Purchase Common Stock, dated March 8, 2002 by Conductus, Inc. to certain
investors (11)
Registration Rights Agreement, dated March 26, 2002, between Conductus, Inc. and
certain investors (11)
Warrant to Purchase Common Stock, dated August 7, 2000, issued by Conductus to
Dobson Communications Corporation (12) *
Form of Series B Preferred Stock and Warrant Purchase Agreement dated September 11,
1998 and September 22, 1998 between Conductus and Series B Investors (13)
Form of Warrant to Purchase Common Stock between Conductus and Series B investors,
dated September 28, 1998, issued by Conductus in a private placement (13)
Form of Series C Preferred Stock and Warrant Purchase Agreement, dated December 10,
1999, between Conductus and Series C Investors (14)
Form of Warrant Purchase Common Stock between Conductus and Series C investors,
dated December 10, 1999, issued by Conductus in a private placement (14)
Form of Warrant to Purchase Common Stock dated March 28, 2003, issued to Silicon
Valley Bank (15)
Form of Warrant (16)
Form of Registration Rights Agreement (16)
Agility Capital Warrant dated May 2004 (17)
Silicon Valley Bank Warrant dated May 2004(17)
Employment Agreement with Terry White
Non-Employee Director Compensation Plan
Accounts Receivable Purchase Modification Agreement with Silicon Valley Bank dated
March 29, 2005 (18)
Settlement Agreement Class Action
Statement of CEO Pursuant to 302 of the Sarbanes-Oxley Act of 2002
Statement of CFO Pursuant to 302 of the Sarbanes-Oxley Act of 2002
Statement of CEO Pursuant to 906 of the Sarbanes-Oxley Act of 2002
Statement of CFO Pursuant to 906 of the Sarbanes-Oxley Act of 2002
(1)
Incorporated by reference from the Registrants Quarterly Report on Form 10-Q filed for the
quarter ended April 3, 1999.
(2)
Incorporated by reference from the Registrants Quarterly Report on Form 10-Q filed for the
quarter ended June 30, 2001.
(3)
Incorporated by reference from the Registrants Quarterly Report on Form 10-Q filed for the
quarter ended July 3, 1999.
Table of Contents
(4)
Incorporated by reference from the Registrants Registration Statement on Form S-1 (Reg. No.
33-56714).
(5)
Incorporated by reference from the Registrants Quarterly Report on Form 10-Q filed for the
quarter ended October 2, 1999.
(6)
Incorporated by reference from the Registrants Registration Statement on Form S-8 (Reg. No.
333-90293).
(7)
Incorporated by reference from the Registrants Annual Report on Form 10-K for the year ended
December 31, 1999.
(8)
Incorporated by reference from Registrants Annual Report on Form 10-K for the year ended
December 31, 2001.
(9)
Incorporated by reference from the Registrants Current Report on Form 8-K, filed October 2,
2002.
(10)
Incorporated by reference from the Registrants Annual Report on Form 10-K filed for the year
ended December 31, 1997.
(11)
Incorporated by reference from the Conductus, Inc.s Registration Statement on Form S-3 (Reg.
No. 333-85928), filed on April 9, 2002.
(12)
Incorporated by reference from Conductus, Inc.s Quarterly Report on Form 10-Q, filed with
the SEC on November 16, 1998.
(13)
Incorporated by reference from Conductus, Inc.s Annual Report on Form 10-K, filed with the
SEC on March 30, 2000.
(14)
Incorporated by reference from Conductus, Inc.s Annual Report on Form 10-K for the year
ended December 31, 1999.
(15)
Incorporate by reference from Registrants Quarterly Report on Form 10-Q for the quarter
ended March 29, 2003.
(16)
Incorporated by reference from Registrants Current Report on Form 8-K filed June 25, 2003.
(17)
Incorporated by reference from Registrants Registration Statement of Form S-3 Reg.
333-89184).
(18)
Incorporated by reference from Registrants Form 8-K dated March 29, 2005
*
Confidential treatment has been previously granted for certain portions of these exhibits.
SUPERCONDUCTOR TECHNOLOGIES INC
.
/s/ Martin S. McDermut
Martin S. McDermut
Senior Vice President, Chief Financial
Officer and Secretary
/s/ Jeffrey A. Quiram
Jeffrey A. Quiram
President and Chief Executive Officer
Exhibit 10.1
Superconductor Technologies Inc.
EMPLOYMENT AGREEMENT
This Employment Agreement (the Agreement ) is made and entered into as of April 11, 2005, by and between Superconductor Technologies Inc., a Delaware corporation (the Company ), and Terry White, an individual (the Executive ), with reference to the following facts:
A. The Company, headquartered in Santa Barbara, California, is the global leader in developing, manufacturing, and marketing superconducting products for wireless networks.
B. Executive is an executive with broad sales experience in the telecommunications industry.
C. The Company wishes to hire Executive for the position of Vice President of Worldwide Sales, and Executive wishes to be hired for such position, on the terms and conditions set forth in this Agreement.
NOW, THEREFORE, based on the above premises and in consideration of the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:
1. Employment with the Company .
1.1 Position and Duties . Subject to the terms set forth herein, the Company agrees to employ Executive as Vice President of Worldwide Sales, and Executive hereby accepts such employment. Executive shall serve in an executive capacity and shall perform such duties as are customarily associated with his position, consistent with the Restated Bylaws of the Company and as reasonably required by the Companys Board of Directors (the Board ). Executive will report to the Companys President and Chief Executive Officer.
1.2 Full Time and Best Efforts . Executive will perform his duties faithfully and to the best of his ability and will devote his full business time and effort to the performance of his duties hereunder. Executive will not engage in any other employment or business activities for any direct or indirect remuneration that would be directly harmful or detrimental to, or that may compete with, the business and affairs of the Company, or that would interfere with his duties hereunder. Executive acknowledges that frequent travel may be necessary in carrying out his duties hereunder
1.3 Company Policies . The employment relationship between the parties shall be governed by the general employment policies and practices of the Company, including but not limited to those relating to protection of confidential information and assignment of inventions, except that when the terms of this Agreement differ from or are in conflict with the Companys general employment policies or practices, this Agreement shall control. This Agreement shall not be effective until the Executive signs the Companys standard Employee Proprietary Information Agreement.
2. At-Will Employment . Executives employment with the Company is at-will and may be terminated at any time without cause by either party. Termination of the employment relationship is the right of each party and will not constitute a breach of this Agreement. No provision of this Agreement shall be construed as conferring upon Executive a right to continue as an employee or executive of the Company or any subsidiary or affiliated entity. In the event
of termination, Executive will voluntarily and immediately resign from any and all director and officer positions he may hold with the Company and subsidiary or affiliate.
3. Compensation .
3.1 Base Salary . The Company will compensate Executive for services rendered hereunder at the rate of Two Hundred Twenty Thousand Dollars ($220,000) per year payable in accordance with the Companys normal payroll practices and subject to payroll deductions as may be necessary or customary for the Companys salaried employees. The Compensation Committee of the Board (the Compensation Committee ) will review, and in its sole discretion may increase, the Base Salary each year.
3.2
Performance Bonus
. The Company will pay Executive an annual performance bonus
based upon achievement of performance goals. The sales incentive bonus for 2005 shall be based on
a mutually acceptable revenue plan for net commercial product sales as follows:
Net Commercial
Product Sales
Bonus Formula
(% of Plan)
(Percentage of Base Salary)
0%
10% to 30% (linear scale)
2.0% of the amount by which net
commercial product sales exceed plan
The term net commercial product sales shall mean the actual net commercial product sales for 2005 as finally determined and set forth in the Companys audited financial statements. The foregoing sales targets and bonus payments are for the full year 2005 and will be pro rated based on Executives actual start date. The bonus structure for future years is to be mutually agreed upon.
3.3 Equity Incentive Compensation .
3.3.1 Option Grants . The Company will grant Executive a non-qualified stock option under its 2003 Equity Incentive Plan to purchase One Million (1,000,000) shares of common stock with a per share exercise price equal to the fair market value of the Companys common stock on the date the stockholders approve an increase in the number of shares of stock authorized for grants under the 2003 Equity Incentive Plan.
3.3.2 Other Terms . All of the options granted under this Section 3.3 will (a) have a term of ten (10) years, (b) vest 25% on the first anniversary of Executives start date with the Company and 75% in 36 equal monthly installments thereafter, (c) have such other terms as are contained in the Companys standard form of stock option agreement presently in use and not inconsistent with the terms of this Agreement and (d) be subject to all the terms and conditions of the Companys 2003 Equity Incentive Plan.
3.3.3 Stockholder Approval of Plan Increase . The Company will submit a request to its stockholders at the upcoming 2005 annual meeting to increase the number of shares of stock authorized for grants under the 2003 Equity Incentive Plan. If the stockholders decline to approve the increase, the Company will grant options to the Companys CEO and to Executive under the 2003 Equity Plan (priced with a per share exercise price equal to the fair market value of the Companys common stock on the date the stockholders decline to approve the increase) as and when additional options become available under the plan as a result of the
2
expiration and forfeiture of other stock options outstanding under the plan until is has fulfilled its obligations to CEO and to Executive under Section 3.3.1. The Company will allocate shares from each available grant sixty percent (60%) to the CEO and forty percent (40%) to Executive. The Company will not grant any further stock options under the 2003 Equity Incentive Plan until it has fulfilled its obligations to the CEO and to Executive under Section 3.3.1.
4. Benefits . Executive shall be entitled to participate in the employee benefit plans and programs of the Company, if any, to the extent that his position, tenure, salary, age, health and other qualifications make him eligible to participate in such plans or programs, subject to the rules and regulations applicable thereto. Subject to Section 10.5.4, the Company reserves the right to cancel or change the benefit plans and programs it offers to its employees at any time.
5. Business Expenses . The Company shall reimburse Executive for reasonable travel, entertainment or other expenses incurred by Executive in the furtherance of or in connection with the performance of Executives duties hereunder, in accordance with the Companys expense reimbursement policy as in effect from time to time.
6. Termination Before a Change of Control .
6.1 Involuntary Termination . If Executives employment with the Company is terminated before a Change of Control due to an Involuntary Termination, then Executive shall be entitled to receive the following:
6.1.1 a severance payment equal to six (6) months of Executives Base Salary as in effect on the date of the Involuntary Termination, paid in accordance with then prevailing payroll practice; and
6.1.2 six (6) months of coverage for Executive and his spouse/dependents under group health, life or other similar insurance plans substantially comparable to the group health, life and other similar insurance plans in which Executive and his spouse/dependents participated on the date of such termination,
6.2 Other Termination . If Executives employment is terminated before a Change of Control for any reason other than an Involuntary Termination, then Executive shall not be entitled to receive severance or other benefits pursuant to this Agreement, but may be eligible for those benefits (if any) as may then be established under the Companys severance and benefits plans and policies existing at the time of such termination.
6.3 Mitigation . The Executive shall not be required to mitigate the amount of any payment or benefit contemplated by this Section 6 (whether by seeking new employment or in any other manner). No such payment shall be reduced by earnings that the Executive may receive from any other source.
7. Change of Control .
7.1 Benefits . In the event of a Change of Control, Executive shall be entitled to receive the following in lieu of any payments or other benefits under Section 6 (Termination Before Change of Control) and regardless of whether Executives employment is continued or terminated (except as expressly provided below in Section 7.1.2 and Section 7.1.3):
7.1.1 accelerated vesting of fifty percent (50%) of Executives unvested stock options;
7.1.2 accelerated vesting of the remaining fifty percent (50%) of Executives options if and only if Executive does not resign during the six month period following the date of the Change of Control; and
3
7.1.3 if Executive is terminated due to an Involuntary Termination, then he shall receive a lump sum payment equal to one (1.0) times Executives Base Salary as in effect on the date of the Involuntary Termination.
7.2 Excise Taxes . In the event that it is determined that any payment or distribution of any type to or for the benefit of the Executive made by the Company, by any of its affiliates, by any person who acquires ownership or effective control of the Company or ownership of a substantial portion of the Companys assets (within the meaning of section 280G of the Internal Revenue Code of 1986, as amended, and the regulations thereunder (the Code )) or by any affiliate of such person, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise (the Total Payments ), would be subject to the excise tax imposed by section 4999 of the Code or any interest or penalties with respect to such excise tax (such excise tax, together with any such interest or penalties, are collectively referred to as the Excise Tax ), then such payments or distributions shall be limited to such amount which would result in no portion of the payments or distributions being subject to the Excise Tax.
7.3 Determination of Excise Tax . All mathematical determinations and all determinations of whether any of the Total Payments are parachute payments (within the meaning of section 280G of the Code) that are required to be made under Section 7.2, shall be made by Deloitte & Touche LLP (or the Companys then current tax accounting firm) (the Tax Firm ), who shall provide their determination (the Determination ), together with detailed supporting calculations regarding the amount of any relevant matters, both to the Company and to the Executive within seven (7) business days of the Executives termination date, if applicable, or such earlier time as is requested by the Company or by the Executive. If applicable, the Tax Firm shall furnish the Executive with a written statement that it has concluded that no Excise Tax is payable (including the reasons therefor) and that the Executive has substantial authority not to report any Excise Tax on the Executives federal income tax return. Any determination by the Tax Firm shall be binding upon the Company and the Executive, absent manifest error. The Company shall pay the fees and costs of the Tax Firm.
8. Condition to Severances Payments . All severance payments and other benefits provided under Sections 6 and 7 are conditioned on Executives continuing compliance with this Agreement and the Companys policies and Executives execution of a release of claims and covenant not to sue substantially in the form provided in Exhibit A upon termination of employment .
9. Indemnification . The Company and Executive will concurrently herewith execute an Indemnification Agreement identical in form and substance to the Indemnification Agreement currently in effect for the Companys other Executive Officers.
10. Definitions .
10.1 Base Salary . Base Salary means Executives annualized base salary under Section 3.1 and as may be subsequently adjusted upward for increases.
10.2 Cause . Cause means the occurrence of anyone or more of the following:
10.2.1 Executives conviction by, or entry of a plea of guilty or nolo contendere in, a court of final jurisdiction for any crime which constitutes a felony in the jurisdiction involved;
4
10.2.2 Executives misappropriation of funds or commission of an act of fraud, whether prior or subsequent to the date hereof, upon the Company;
10.2.3 willful disregard by Executive in the scope of Executives services to the Company;
10.2.4 a breach by Executive of a material provision of this Agreement;
10.2.5 a failure of Executive to substantially perform his duties hereunder; or
10.2.6 a failure of Executive to follow the lawful mandates of the Board.
Notwithstanding the foregoing, Executive shall not be deemed to have been terminated for Cause without (a) reasonable notice to Executive setting forth the reasons for Companys intention to terminate for Cause and (b) an opportunity for Executive to be heard before the Board.
10.3 Change of Control . Change of Control means the occurrence of any of the following events on or after the effective date of this Agreement:
10.3.1 When any person, as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended, is or becomes the beneficial owner (as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended), directly or indirectly, of securities of the Company representing thirty percent (30%) or more of the combined voting power of the Companys then outstanding securities entitled to vote generally in the election of directors, other than the following persons:
10.3.1.1 the Company,
10.3.1.2 a subsidiary of the Company,
10.3.1.3 a Company employee benefit plan, including any trustee of such plan acting as trustee, or
10.3.1.4 any person who, as of the effective date of this Agreement, has publicly disclosed in filings with the Securities and Exchange Commission the beneficial ownership of more than 5% of the combined voting power of the Companys outstanding securities entitled to vote generally in the election of directors;
10.3.2 The stockholders of the Company approve a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation, or the stockholders of the Company approve an agreement for the sale or disposition by the Company of all or substantially all the Companys assets;
10.3.3 A change in the composition of the Board of Directors of the Company, as a result of which fewer than a majority of the directors are Incumbent Directors. Incumbent Directors shall mean directors who either (a) are directors of the Company as of the effective date of this Agreement, or (b) are elected, or nominated for election, to the Board of Directors of the Company with the affirmative votes of at least a majority of the Incumbent Directors at the time of such election or nomination (but shall not include an individual whose election or nomination is in connection with an actual or threatened proxy contest relating to the election of directors to the Company);
5
10.3.4 The sale, transfer or other disposition of all or substantially all of the Companys assets; or
10.3.5 The stockholders of the Company approve the dissolution or liquidation of the Company.
10.4 Executive Officer shall have the meaning set forth in Rule 3b-7 under the Securities Exchange Act of 1934, as amended.
10.5 Involuntary Termination . Involuntary Termination means the occurrence of any one or more of the following:
10.5.1 without Executives express written consent, a material reduction of Executives duties or responsibilities relative to Executives duties or responsibilities in effect immediately prior to such reduction, or the removal of Executive from such duties and responsibilities, unless Executive is provided with comparable duties and responsibilities over the same business unit;
10.5.2 without Executives express written consent, a material reduction of the facilities and perquisites (including office space and location) available to Executive immediately prior to such reduction;
10.5.3 without Executives express written consent, a reduction by the Company of Executives Base Salary in effect immediately prior to such reduction, unless it occurs in connection with a restructuring or other cost-cutting measure as evidenced by a comparable reduction in the base salary of all Executive Officers;
10.5.4 a material reduction by the Company in the kind or level of employee benefits to which the Executive is entitled immediately prior to such reduction with the result that the Executives overall benefits package is significantly reduced;
10.5.5 any purported termination of the Executive by the Company which is not effected for Cause or for which the grounds relied upon are not valid; or
10.5.6 the failure of the Company to obtain the assumption of this Agreement by any successors contemplated in Section 12.
The conversion of the Company into a subsidiary, division or other business unit of any successor entity shall not constitute a triggering event under Section 10.5.1 provided Executive has substantially the same duties and responsibilities over such subsidiary, division or other business unit immediately before and after such conversion.
11. Advice of Counsel . Executive acknowledges that he has been represented by counsel in the negotiation of this Agreement and is fully aware of his rights and obligations under this Agreement.
12. Successors .
12.1 Companys Successors . Any successor to the Company (whether direct or indirect and whether by purchase, lease, merger, consolidation, liquidation or otherwise) to all or substantially all of the Companys business and/or assets shall assume the obligations under this Agreement and agree expressly to perform the obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession. For all purposes under this Agreement, the term Company , shall include any successor to the Companys business and/or assets which executes and delivers the assumption agreement described in this Section 12.1 or which becomes bound by the terms of this Agreement by operation of law.
6
12.2 Executives Successors . Without the written consent of the Company, Executive shall not assign or transfer this Agreement or any right or obligation under this Agreement to any other person or entity. Notwithstanding the foregoing, the terms of this Agreement and all rights of Executive hereunder shall inure to the benefit of, and be enforceable by, Executives personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.
13. Notice Clause .
13.1 Manner . Any notice hereby required or permitted to be given shall be sufficiently given if in writing and upon mailing by registered or certified mail, postage prepaid, to either party at the address of such party or such other address as shall have been designated by written notice by such party to the other party .
13.2 Effectiveness . Any notice or other communication required or permitted to be given under this Agreement will be deemed given on the day when delivered in person, or the business day after the day on which such notice was mailed in accordance with Section 13.1.
14. Governing Law . This Agreement shall be governed by and construed in accordance with the internal substantive laws, but not the choice of law rules, of the state of California.
15. Arbitration . Any controversy or claim arising out of or relating to this Agreement, or the breach thereof, shall be settled by arbitration in Los Angeles in accordance with the Commercial Arbitration Rules of the American Arbitration Association. Discovery shall be permitted to the same extent as in a proceeding under the Federal Rules of Civil Procedure, including (without limitation) such discovery as is specifically authorized by section 1283.05 of the California Code of Civil Procedure, without need of prior leave of the arbitrator under section 1283.05(e) of such Code. Judgment on the award rendered by the arbitrator may be entered in any court having jurisdiction thereof. The Company shall bear the expense of the arbitrator.
16. Attorneys Fees for Executive . The Company will reimburse Executive for up to $2,000 of legal fees and costs incurred by Executive in connection with the negotiation of this Agreement. Further, if any litigation or arbitration is commenced (including any proceedings in a bankruptcy court) between the parties concerning any provision of this Agreement and Executive is the prevailing party in such proceeding, the Executive shall be entitled, in addition to such other relief as may be granted, to recover his attorneys reasonable fees and costs incurred by reason of such litigation or arbitration. The prevailing party shall be determined by the court or arbitrator based upon an assessment of which partys major arguments or positions taken in the proceedings could fairly be said to have prevailed over the other partys major arguments or positions on major disputed issues.
17. Severability . The invalidity or unenforceability of any provision of this Agreement, or any terms hereof, shall not affect the validity or enforceability of any other provision or term of this Agreement.
18. Confidentiality and Trading Restrictions . The parties agree the existence and negotiation of this Agreement, and any non-public information exchanged in connection therewith, are confidential (collectively, Confidential Information ). They will not disclose any Confidential Information except as provided herein. Either party may disclose Confidential Information to its employees and advisors who are required to have the information for the purpose of providing assistance in the negotiations. The Company may disclose the existence of the negotiations and this Agreement at such time as it determines public disclosure is required under the applicable securities laws. The parties will not use any Confidential
7
Information except for the decision whether to enter into an employment relationship and negotiating the terms of employment. Executive will refrain from trading in the Companys securities until 72 hours after public disclosure by Company of this Agreement. Thereafter, Executive may trade in the Companys securities only in compliance with the Companys Insider Trading Policy.
19. Integration . This Agreement and any other agreement referred to herein or executed contemporaneously herewith represent the entire agreement and understanding between the parties as to the subject matter herein and supersedes all prior or contemporaneous agreements whether written or oral. No waiver, alteration, or modification of any of the provisions of this Agreement shall be binding unless in writing and signed by duly authorized representatives of the parties hereto.
20. Taxes . All payments made pursuant to this Agreement shall be subject to withholding of applicable income and employment taxes.
21. Counterparts and Facsimile . This Agreement may be executed in counterparts and by facsimile.
*** [NEXT PAGE IS SIGNATURE PAGE] ***
8
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed, as of the day and year first above written.
Executive | Company | |
|
SUPERCONDUCTOR TECHNOLOGIES INC. | |
|
||
|
||
Terry White
|
Jeffrey A. Quiram, President and Chief Executive Officer |
S-1
EXHIBIT A
Form of Release of Claims and Covenant Not To Sue
In consideration of the payments and other benefits that Superconductor Technologies Inc. (the Company ) is providing to ____________( Executive ) under the Employment Agreement entered into by and between Executive and the Company, dated April ___, 2005, the Executive, on his/her own behalf and on behalf of Executives representatives, agents, heirs and assigns, waives, releases, discharges and promises never to assert any and all claims, demands, actions, costs, rights, liabilities, damages or obligations of every kind and nature, whether known or unknown, suspected or unsuspected that Executive ever had, now have or might have as of the date of Executives termination of employment with the Company against the Company or its predecessors, parent, affiliates, subsidiaries, stockholders, owners, directors, officers, employees, agents, attorneys, insurers, successors, or assigns (including all such persons or entities that have a current and/or former relationship with the Company) (the Released Parties ) for any claims arising from or related to Executives employment with the Company, its parent or any of its affiliates and subsidiaries and the termination of that employment.
These released claims also specifically include, but are not limited to, any claims arising under any federal, state and local statutory or common law, such as (as amended and as applicable) Title VII of the Civil Rights Act, the Age Discrimination in Employment Act, the Americans With Disabilities Act, the Employee Retirement Income Security Act, the Family Medical Leave Act, the Equal Pay Act, the Fair Labor Standards Act, the Industrial Welfare Commissions Orders, the California Fair Employment and Housing Act, the California Constitution, the California Government Code, the California Labor Code and any other federal, state or local constitution, law, regulation or ordinance governing the terms and conditions of employment or the termination of employment, and the law of contract and tort and any claim for attorneys fees; provided, however, that Executive does not release or discharge the Released Parties from (i) any of the Companys obligations to him under the Employment Agreement, and (ii) any vested benefits to which he may be entitled under any employee benefit plan or program subject to ERISA.
Furthermore, the Executive acknowledges that this waiver and release is knowing and voluntary and that the consideration given for this waiver and release is in addition to anything of value to which Executive was already entitled. Executive acknowledges that there may exist facts or claims in addition to or different from those which are now known or believed by Executive to exist. Nonetheless, this Agreement extends to all claims of every nature and kind whatsoever, whether known or unknown, suspected or unsuspected, past or present. Executive also expressly waives the provisions of California Civil Code section 1542, which provides: A general release does not extend to claims which the creditor does not know or suspect to exist in his favor at the time of executing the release, which if known by him/her must have materially affected his settlement with the debtor. With respect to the claims released in the preceding sentences, the Executive will not initiate or maintain any legal or administrative action or proceeding of any kind against the Company or its predecessors, parent, affiliates, subsidiaries, stockholders, owners, directors, officers, employees, agents, successors, or assigns (including all such persons or entities that have a current or former relationship with the Company), for the purpose of obtaining any personal relief, nor assist or participate in any such proceedings, including any proceedings brought by any third parties (except as otherwise required or permitted by law). The Executive further acknowledges that he/she has been advised by this writing that:
A-1
| he/she should consult with an attorney prior to executing this release; | |||
| he/she has at least twenty-one (21) days within which to consider this release; | |||
| he/she has up to seven (7) days following the execution of this release by the parties to revoke the release; and | |||
| this release shall not be effective until such seven (7) day revocation period has expired. |
Executive agrees that the release set forth above shall be and remain in effect in all respects as a complete general release as to the matters released.
EXECUTIVE
|
||
|
||
|
Date: |
A-2
Exhibit 10.2
Superconductor Technologies Inc.
Compensation Policy for Non-Employee Directors
(March 18, 2005)
I. Introduction
Similar to its philosophy for the compensation of executive officers, the Board of Directors (the Board ) of Superconductor Technologies Inc. (the Company ) believes that the Companys future success depends in part on its ability to attract and retain highly qualified individuals to serve on the Board. With this goal in mind, the Board periodically reviews the compensation arrangements for non-employee directors. Based on those reviews and the consideration of director compensation practices at comparable companies, the Board has from time to time approved certain compensation policies and practices which it believes are necessary to maintain a competitive compensation package for its non-employee directors. The Board has further concluded that it would be appropriate and useful to consolidate and formalize those policies and practices in one comprehensive document.
II. Scope of Policy
This policy governs the compensation of non-employee directors of the Company. For purposes of this policy, a non-employee director means a director who (i) is not employed as an officer or other employee of the Company or any of its subsidiaries and (ii) does not receive more than $60,000 in compensation, directly or indirectly, in the relevant year from the Company or any of its subsidiaries for services as a consultant or in any other capacity other than as a director.
III. Board Fees .
A. Annual Retainer . Non-employee directors will receive an annual retainer of $10,000 per year provided the director attends at least 75% of the regular meetings of the Board. Attendance may be in person or by telephone, but attendance in person is encouraged. The Company will pay the retainer in quarterly installments of $2,500. Any non-employee Chairman of the Board will receive an annual retainer of $20,000 per year.
B. Meeting Fee . Non-employee directors (other than the Chairman of the Board) will receive a $2,000 meeting fee for attendance at each meeting of the Board. The Chairman of the Board will receive a $4,000 meeting fee for attendance at each meeting of the Board. Directors will receive meetings fees for attendance in person or, where necessary, by telephone. However, no meeting fees will be paid for participation in meetings of the Board which are held entirely by telephone, except as otherwise agreed by the Board. The Company will pay meeting fees promptly following each meeting.
C. Committee Service . The Chairman of the Audit Committee will receive an annual retainer of $5,000 per year. The Chairman of the Compensation Committee and the Chairman of the Governance and Nominating will each receive an annual retainer of $3,000 per year. The Company will pay the annual retainers in quarterly installments. There will be additional compensation for service on committees of the Board which will consist of stock option awards as specified below in Section IV(C).
IV. Stock Option Awards
A. Initial Grants . Non-employee directors will receive a stock option grant of 25,000 shares of common stock upon their initial election or appointment to the Board. The exercise price will be the closing price of the common stock on the date of their appointment or election, as applicable. These options will vest in four equal annual installments with the first 25% vesting on the twelve month anniversary of the date of grant.
B. Annual Service Grants . Non-employee directors (other than the Chairman of the Board) who have served for at least six months will receive an annual stock option grant of 15,000 shares of common stock on the date of each annual meeting of stockholders at which they are re-elected. The Chairman of the Board will receive an annual stock option grant of 20,000 shares of common stock on the same terms. The exercise price for the annual option grants will be the closing price of the common stock on the date of the annual stockholder meeting.
C. Committee Service Grants . Non-employee directors (other than the committee chairman) will receive a stock option grant of 2,000 shares of common stock for attendance at each committee meeting. The chairman of the committee will receive a stock option grant of 4,000 shares of common stock for attendance at each committee meeting. Committee members may attend meetings in person or, where necessary, by telephone, and committee service grants will apply to telephonic committee meetings. The exercise price for the committee service grants will be the closing price of the common stock on the date of the applicable committee meeting.
D. Grant Date, Duration and Vesting . Unless otherwise specified in this policy, all stock options awarded to non-employee directors under this policy will (1) be non-qualified stock options, (2) have an effective grant date that is the same as the date used to determine the exercise price, (3) have a duration of ten years from the date of grant, and (4) vest in two equal annual installments with the first 50% vesting on the twelve month anniversary of the date of grant.
V. Expense Reimbursement
Non-employee directors are entitled to reimbursement for all reasonable and customary out of pocket and travel expenses incurred in the normal course of Company business.
2
VI. Administration and Interpretation
The Board will have complete discretion to resolve any questions relating to the administration or interpretation of this policy, and their decision will be final and binding on all non-employee directors. Unless otherwise required by the context, all references in this policy to a year refer to the year between annual stockholder meetings.
VII. Amendments
The Board has adopted this policy based on the business and economic conditions in existence at the time of adoption and intends to periodically review the policy in light of changes in those conditions. Therefore, the Board reserves the right to amend this policy at any time and in any manner that it deems necessary, appropriate or desirable to reflect the best interests of the Company. The Board also reserves the right to vary from the policy from time to time without amending it and shall do so by resolution of the Board.
*** [END OF DOCUMENT] ***
3
Exhibit 10.4
IRELL & MANELLA LLP
David Siegel (101355)
dsiegel@irell.com
Daniel P. Lefler (151253)
dlefler@irell.com
Richard H. Zelichov (193858)
rzelichov@irell.com
Pamela K. Graham (216309)
pgraham@irell.com
1800 Avenue of the Stars, Suite 900
Los Angeles, California 90067-4276
Telephone: (310) 277-1010
Facsimile: (310) 203-7199
Attorneys for Defendants
SUPERCONDUCTOR TECHNOLOGIES INC.,
M. PETER THOMAS, and MARTIN S. McDERMUT
[additional counsel on signature page]
UNITED STATES DISTRICT
COURT
CENTRAL DISTRICT OF CALIFORNIA
WESTERN DIVISION
)
MARC A. BACKHAUS, on Behalf of
)
Case No. CV-04-2680 DT (JTLx)
Himself and All Others Similarly Situated,
)
Consolidated with
)
CV-04-02848 DT and CV-04-02927 DT
)
)
STIPULATION OF SETTLEMENT
)
)
CLASS ACTION PSLRA
)
)
)
)
)
)
)
)
PLACE:
255 East Temple Street
)
COURTROOM:
880
)
ALL ACTIONS
)
Honorable Dickran Tevrizian
)
)
STIPULATION OF SETTLEMENT
This Stipulation of Settlement (the Stipulation), dated as of March 8, 2005, is made and entered into by and among the following parties (as defined further in Section V herein) to the above-entitled action: (i) Lead Plaintiffs (as defined below), on behalf of themselves and each of the Settlement Class Members (as defined below), by and through their counsel of record in the action; and (ii) the Defendants (as defined below), by and through their counsel of record in the Class Action (collectively the Settling Parties). The Stipulation is intended by the Settling Parties to fully, finally and forever resolve, discharge and settle the Released Claims (as defined below), upon and subject to the terms and conditions hereof.
I. THE CLASS ACTION
A. The Class Actions
On and after April 16, 2004, three federal securities class action complaints, including Marc A. Backhaus v. Superconductor Technologies Inc., et al. , Case No. CV04-2680 DT (JTLx), were filed against Superconductor Technologies Inc. (STI), M. Peter Thomas, and Martin S. McDermut in the Central District of California. By an order of the Honorable Dickran Tevrizian dated on or about August 2, 2004, these complaints were consolidated under the caption Backhaus v. Superconductor Technologies Inc., et al. , Case No. CV04-2680 DT (JTLx) (the Class Action). In the same order, the Court appointed Marc A. Backhaus and Jay Jakubowitz as lead plaintiffs (Lead Plaintiffs) and appointed Federman & Sherwood as lead counsel (Lead Plaintiffs Counsel).
On October 4, 2004 after conducting further review of STIs press releases and public filings and after hiring a private investigator to interview certain of STIs former employees, Lead Plaintiffs Counsel filed a First Amended Consolidated Class Action Complaint (the First Amended Complaint). The First Amended Complaint asserted claims against STI and the Individual Defendants for alleged violations of sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. The First Amended Complaint sought recovery for purchasers of common stock during the
- 1 -
period from January 9, 2004 through March 1, 2004, inclusive. The First Amended Complaint alleged that during the Settlement Class Period (as defined below), STI issued false and misleading statements that materially inflated STIs stock price. Lead Plaintiffs claimed primarily that STI issued false and misleading projections of its first quarter total net revenues.
II. PRE-TRIAL PROCEEDINGS, INVESTIGATION, AND DISCOVERY
A. Investigation and Research Conducted by Plaintiffs
Lead Plaintiffs Counsel has conducted an investigation during the prosecution of the Class Action. This investigation has included, inter alia , (i) consultations with experts; (ii) review of STIs public filings, annual reports, and other public statements; and (iii) research of the applicable law with respect to the claims asserted in the Class Action and the potential defenses thereto. In addition, by order dated December 1, 2004, the Court granted in part a motion filed by Lead Plaintiffs Counsel to limit the scope of certain confidentiality agreements signed by former STI employees. Pursuant to this order, the parties jointly retained the Honorable Enrique Romero (ret.) to serve as a Special Master to implement the relief prescribed in the Courts December 1, 2004 order, and questionnaires were sent to 122 of STIs former employees concerning the allegations of the First Amended Complaint. Lead Plaintiffs Counsel has inspected and reviewed the responses of all former employees who returned the questionnaires.
B. Pre-Trial Proceedings
On November 18, 2004, the Defendants filed a Motion to Dismiss the First Amended Complaint, which Lead Plaintiffs opposed by Memorandum dated December 22, 2004. The hearing on the Motion to Dismiss has been taken off calendar in light of the Settlement.
C. Discovery
Defendants have agreed to provide Lead Plaintiffs Counsel with certain documents relating to STIs revenues and projections for the fourth quarter of 2003 and
- 2 -
first quarter of 2004 so that Lead Plaintiffs Counsel can conduct additional due diligence with respect to the Stipulation of Settlement.
III. SETTLEMENT NEGOTIATIONS AND MEDIATION
From around December 2004 through February 2005, the parties conducted extensive informal settlement discussions, in which the parties, among other things, presented their respective views regarding the merits of the Class Action and defenses, the evidence, and damages analyses. When the informal discussions did not prove fruitful, the parties opted to continue their discussions through a formal mediation process before the Honorable Daniel Weinstein (ret.), in an effort to settle the Class Action.
On February 11, 2005, the parties to the Class Action, through their respective counsel and representatives, participated in a mediation session with Judge Weinstein. During this meeting, which took place after Judge Weinstein received briefs from the parties, the parties and Judge Weinstein discussed, among other things, the parties respective claims and defenses, expert damages analyses, legal analyses, the discovery and motion practice conducted and expected to be conducted in the Class Action, the evidence expected to be offered by the parties at trial, the Lead Plaintiffs ability to meet the heightened pleading standards of the Private Securities Litigation Reform Act of 1995, STIs financial position, initial evidence and other important factual and legal issues and matters relating to the merits of the Class Action. At the conclusion of the mediation, Judge Weinstein orally recommended that the parties approve the settlement discussed and negotiated during the mediation.
IV. CLAIMS OF LEAD PLAINTIFFS AND BENEFITS OF SETTLEMENT
Lead Plaintiffs believe that the claims asserted in the Class Action have merit and that the evidence developed to date in the Class Action supports the claims asserted. Lead Plaintiffs assert, and believe they would present supporting evidence at trial, that Defendants caused the price of STI common stock to be artificially inflated during the Settlement Class Period by the issuance of materially false statements and by omitting to
- 3 -
state material information concerning STI and that as a result Lead Plaintiffs and Settlement Class Members were injured.
Lead Plaintiffs Counsel recognize and acknowledge the expense and length of continued proceedings necessary to prosecute the Class Action through trial and through appeals. Lead Plaintiffs Counsel also have taken into account the uncertain outcome and the risk of any litigation, especially in complex actions such as the Class Action, as well as the difficulties and delays inherent in such litigation. Lead Plaintiffs Counsel also are mindful of the inherent problems of proof under and possible defenses to the violations asserted in the Class Action, including the defenses asserted by Defendants during the Class Action, in motions on the pleadings, settlement negotiations and in the mediation proceedings. In addition, Lead Plaintiffs Counsel investigated STIs financial position and has noted that STI has limited financial resources to pay any judgment even if Lead Plaintiffs succeeded in the Class Action. Lead Plaintiffs Counsel also recognized that any substantial judgment in the Class Action might result in STIs bankruptcy which could leave Lead Plaintiffs and the Settlement Class with no possibility of recovery. Moreover, Lead Plaintiffs Counsel has reviewed the terms of STIs insurance coverage and noted that the policy is reduced by defense costs incurred in defending the Class Action.
In light of the foregoing, Lead Plaintiffs Counsel agree with Lead Plaintiffs and believe that the settlement set forth in the Stipulation confers substantial benefits upon the Settlement Class (as defined below) and Settlement Class Members. Based on their evaluation, Lead Plaintiffs Counsel have determined that the settlement set forth in the Stipulation is in the best interests of the Lead Plaintiffs and the Settlement Class.
V. DEFENDANTS STATEMENT AND DENIALS OF WRONGDOING AND LIABILITY
The Defendants have denied and continue to deny each and all of the claims and contentions alleged by Lead Plaintiffs on behalf of the Settlement Class. The Defendants also have denied and continue to deny, inter alia , the allegations that the prices of STI stock were artificially inflated by reasons of alleged misrepresentations, non-disclosures or
- 4 -
otherwise, or that Lead Plaintiffs or the Settlement Class were harmed by the conduct alleged in the Class Action. Defendants believe that throughout the Settlement Class Period they fully and adequately disclosed all material facts regarding STI and made no misrepresentations of material facts regarding STI.
Nonetheless, the Defendants have concluded that further conduct of the Class Action would be protracted and expensive, and that it is desirable that the Class Action be fully and finally settled in the manner and upon the terms and conditions set forth in this Stipulation in order to limit further expense, inconvenience and distraction, to dispose of the burden of protracted litigation, and to permit the operation of the Companys business without further distraction and diversion of the Companys executive personnel with respect to matters at issue in the Class Action. The Defendants also have taken into account the uncertainty and risks inherent in any litigation, especially in complex cases like this Class Action.
The Defendants have, therefore, determined that it is desirable and beneficial to them that the Class Action be settled in the manner and upon the terms and conditions set forth in this Stipulation. The Defendants enter into this Stipulation and Settlement without in any way acknowledging any fault, liability, or wrongdoing of any kind. There has been no adverse determination by any court or otherwise against any of the Defendants on the merits of the claims asserted by Lead Plaintiffs. Neither this Stipulation, nor any of its terms or provisions, nor any of the negotiations or proceedings connected with it, shall be construed as an admission or concession by any of the Defendants of the merit or truth of any of the allegations or wrongdoing of any kind on the part of any of the Defendants. The Defendants enter into this Stipulation and Settlement based upon, among other things, the parties agreement herein that, to the fullest extent permitted by law, neither this Stipulation nor any of its terms or provisions, nor any of the negotiations or proceedings connected therewith, shall be offered as evidence in the Class Action or in any pending or future civil, criminal, or administrative action or other proceeding to establish any liability or admission by any of the Defendants or any of their respective Related Entities or any other
- 5 -
matter adverse to any of the Defendants or any of their respective Related Entities, except as expressly set forth herein.
VI. TERMS OF STIPULATION AND AGREEMENT OF SETTLEMENT
NOW, THEREFORE, IT IS HEREBY STIPULATED AND AGREED by and among Lead Plaintiffs (for themselves and the Settlement Class Members), and the Defendants, by and through their respective counsel of record, that, subject to the approval of the Court, the Class Action and the Released Claims shall be finally and fully compromised, settled and released, and the Class Action shall be dismissed with prejudice, upon and subject to the terms and conditions of the Stipulation, as follows:
1. | Definitions |
As used in the Stipulation the following terms have the meanings specified below:
1.1 Authorized Claimant means any Settlement Class Member whose claim for recovery has been allowed pursuant to the terms of the Stipulation.
1.2 Claimant means any Settlement Class Member who files a Proof of Claim in such form and manner, and within such time, as the Court shall prescribe.
1.3 Claims Administrator means RSM McGladrey, Inc., 512 Township Line Road, One Valley Square, Suite 250, Blue Bell, PA 19422.
1.4 Company or STI means defendant Superconductor Technologies Inc., a Delaware corporation, and all of its predecessors, successors, present and former parents, subsidiaries, divisions and related or affiliated entities.
1.5 Defendants means STI, M. Peter Thomas, and Martin S. McDermut.
1.6 Defendants Insurer means National Union Fire Insurance Company of Pittsburgh, Pa.
1.7 Effective Date means the first date by which all of the events and conditions specified in Section V, ¶ 9.1(a)-(e) of the Stipulation have been met and have occurred.
1.8 Escrow Agent means Federman & Sherwood.
- 6 -
1.9 Final means: (i) The date of final affirmance on an appeal from the Judgment, the expiration of the time for a petition for a writ of certiorari to review the Judgment and, if certiorari be granted, the date of final affirmance of the Judgment following review pursuant to that grant; or (ii) the date of final dismissal of any appeal from the Judgment or the final dismissal of any proceeding on certiorari to review the Judgment; or (iii) if no appeal is filed, the expiration date of the time for the filing or noticing of any appeal from the Courts judgment approving the Stipulation substantially in the form and content of Exhibit B hereto, i.e. , thirty-five (35) days after entry of the Judgment (or, if the date for taking an appeal or seeking review shall be extended beyond this time by order of the Court, by operation of law or otherwise, or if such extension is requested, the date of expiration of any extension if any appeal or review is not sought). Any proceeding or order, or any appeal or petition for a writ of certiorari pertaining solely to any plan of allocation and/or application for attorneys fees, costs or expenses, shall not in any way delay or preclude the Judgment from becoming Final.
1.10 Individual Defendants means M. Peter Thomas and Martin S. McDermut.
1.11 Judgment means the judgment to be rendered by the Court dismissing the Class Action with prejudice, substantially in the form and content attached hereto as Exhibit B.
1.12 Parties means, collectively, each of the Defendants and Lead Plaintiffs on behalf of themselves and the members of the Settlement Class.
1.13 Person means an individual, corporation (including all divisions and subsidiaries), partnership, limited partnership, association, joint stock company, estate, legal representative, trust, unincorporated association, government or any political subdivision or agency thereof, and any business or legal entity and their spouses, heirs, predecessors, successors, representatives, or assigns.
1.14 Lead Plaintiffs means Marc A. Backhaus and Jay Jakubowitz.
- 7 -
1.15 Lead Plaintiffs Counsel means: Federman & Sherwood, 120 North Robinson Avenue, Suite 2720, Oklahoma City, Oklahoma 73102, telephone (405) 235-1560, facsimile (405) 239-2112.
1.16 Notice and Administration Fund means the principal amount of $50,000.00 deposited by STI in a fund to be managed by the Claims Administrator to be used solely for costs and expenses reasonably and actually incurred in connection with providing notice to the Settlement Class, locating Settlement Class Members, soliciting Settlement Class claims, assisting with the filing of claims, administering and distributing the Settlement Fund to Members of the Settlement Class, processing Proofs of Claim and Releases, and paying escrow fees and costs, if any.
1.17 Plan of Allocation means a plan or formula of allocation of the Settlement Fund to be prepared by Lead Plaintiffs Counsel which shall be described in the Notice of Pendency and Proposed Settlement of Class Action to be sent to Settlement Class Members in connection with the settlement whereby the Settlement Fund shall be distributed to Authorized Claimants after payment of expenses of notice and administration of the settlement, any taxes, penalties or interest or tax preparation fees owed by the Settlement Fund, and such attorneys fees, costs, expenses and interest as may be awarded by the Court. Any Plan of Allocation is not part of the Stipulation.
1.18 Related Parties means each of a Defendants past or present directors, officers, employees, partners, principals, agents, underwriters, insurers, co-insurers, reinsurers, controlling shareholders, any entity in which the Defendant and/or any member(s) of any Defendants immediate family has or have a controlling interest, attorneys, accountants, auditors, banks, investment banks or investment bankers, advisors, analysts, personal or legal representatives, insurers, reinsurers, predecessors, successors, parents, subsidiaries, divisions, joint ventures, assigns, spouses, heirs, associates, related or affiliated entities, any members of their immediate families, or any trust of which any Defendant is the trustee or settlor or which is for the benefit of any Defendant and/or member(s) of his family. Any retail securities broker retained by a Settlement Class
- 8 -
Member (and not retained by STI) that specifically recommended STI stock on the secondary market to a Settlement Class Member is excluded from the definition of Related Parties.
1.19 Released Claims shall collectively mean all claims (including Unknown Claims as defined in ¶ 1.27 hereof), demands, rights, liabilities and causes of action of every nature and description whatsoever, known or unknown, whether in contract, tort, equity or otherwise, whether or not concealed or hidden, asserted or that might have been asserted in this or any other forum or proceeding, including, without limitation, claims for negligence, gross negligence, indemnification, breach of duty of care and/or breach of duty of loyalty, fraud, misrepresentation, breach of fiduciary duty, negligent misrepresentation, unfair competition, insider trading, professional negligence, mismanagement, corporate waste, breach of contract, or violations of any state or federal statutes, rules or regulations, by or on behalf of Lead Plaintiffs, the Settlement Class, or any Settlement Class Member against the Released Persons (as defined below) which are based upon or related to the purchase or acquisition of STI common stock by any Settlement Class Member during the Settlement Class Period and the facts, transactions, events, occurrences, acts, disclosures, statements, omissions or failures to act which were or could have been alleged in the Class Action, or any other forum.
1.20 Released Persons means each and all of the Defendants and their respective Related Parties.
1.21 Representative Plaintiffs means each of the plaintiffs who filed a complaint in the Class Action, including, but not limited to the Lead Plaintiffs.
1.22 Representative Plaintiffs Counsel means each counsel who has appeared as counsel for any of the Representative Plaintiffs in the Class Action, including, but not limited to Lead Plaintiffs Counsel.
1.23 Settlement Class means all Persons (except Defendants, members of the immediate family of any Defendant, any entity in which any Defendant has a controlling interest, and the legal representatives, heirs, successors or assigns of any such
- 9 -
excluded party) who purchased or otherwise acquired STI common stock during the period from January 9, 2004 through March 1, 2004, inclusive, excluding those persons who timely and validly request exclusion from the Settlement Class.
1.24 Settlement Class Member or Member of the Settlement Class means a Person who falls within the definition of the Settlement Class as set forth in ¶ 1.23, above.
1.25 Settlement Class Period means the period from January 9, 2004 through March 1, 2004, inclusive.
1.26 Settlement Fund means the principal amount of Four Million Dollars ($4,000,000) in cash, for and on behalf of the Defendants, less the cost of notice, plus interest earned or accrued thereon.
1.27 Unknown Claims means any Released Claims which the Lead Plaintiffs or any Settlement Class Member does not know or suspect to exist in his, her or its favor at the time of the release of the Released Persons which, if known by him, her or it, might have affected his, her or its settlement with and release of the Released Persons, or might have affected his, her or its decision not to object to, or opt out of, this settlement. With respect to any and all Released Claims, the Parties stipulate and agree that, upon the Effective Date, the Lead Plaintiffs expressly waive and relinquish, and the Settlement Class Members shall be deemed to have, and by operation of the Judgment shall have expressly waived and relinquished, to the fullest extent permitted by law, the provisions, rights, and benefits of § 1542 of the California Civil Code, which provides:
A general release does not extend to claims which the creditor does not know or suspect to exist in his favor at the time of executing the release, which if known by him must have materially affected his settlement with the debtor.
The Lead Plaintiffs expressly waive and the Settlement Class Members shall be deemed to, and upon the Effective Date and by operation of the Judgment shall, have waived any and all provisions, rights and benefits conferred by any law of the United States or of any state or territory of the United States, or principle of common law, which is similar, comparable or equivalent to § 1542 of the California Civil Code. The Lead Plaintiffs and the
- 10 -
Settlement Class Members may hereafter discover facts in addition to or different from those which he, she or it now knows or believes to be true with respect to the subject matter of the Released Claims, but each of them hereby stipulate and agree that the Lead Plaintiffs do settle and release, and each Settlement Class Member shall be deemed to, upon the Effective Date and by operation of the Judgment shall have, fully, finally, and forever settled and released any and all Released Claims, known or unknown, suspected or unsuspected, contingent or non-contingent, whether or not concealed or hidden, which now exist, or heretofore have existed upon any theory of law or equity now existing or coming into existence in the future, including, but not limited to, conduct which is negligent, intentional, with or without malice, or a breach of any duty, law or rule, without regard to the subsequent discovery or existence of such different or additional facts. The Parties acknowledge that the foregoing waiver was bargained for and a key element of the Settlement of which this release is a part.
2. The Settlement Funds .
2.1 Defendants shall cause the Settlement Fund to be transferred to the Escrow Agent as follows: (a) by April 12, 2005 or (b) within ten (10) business days after preliminary approval of this Stipulation as provided in ¶ 5.1 below, whichever is later (the Funding Date), Defendants Insurer shall wire transfer $4,000,000 to the Escrow Agent.
2.2 STI shall cause the Notice and Administration Fund to be transferred to the Claims Administrator within five (5) business days after preliminary approval of this Stipulation as provided in ¶ 5.1 below.
3. Certification of the Settlement Class .
3.1 For the sole purpose of implementation, approval and consummation of the Settlement, the Settling Parties stipulate and agree that the Court may enter an order certifying the Settlement Class, appointing the Lead Plaintiffs as the representatives of the Settlement Class, and appoint Lead Plaintiffs Counsel as counsel for the Settlement Class.
3.2 Certification of the Settlement Class and appointment of Lead Counsel as counsel for the Settlement Class, as set forth herein, shall be binding only with respect
- 11 -
to the Settlement set forth in the Stipulation. In the event that this Stipulation is terminated or cancelled or that the Effective Date does not occur for any reason, the stipulated certification of the Settlement Class shall be vacated and the Class Action shall proceed as though the Settlement Class had never been certified. Except to effectuate the Settlement, neither the Settling Parties, their respective counsel, nor any member of the Settlement Class shall cite, present as evidence or legal precedent, rely upon, make reference to or otherwise make any use whatsoever of this stipulated certification of the Settlement Class, in this Class Action or in any other proceeding.
4. | Administration Of The Settlement Fund |
(a) The Escrow Agent
4.1 The Escrow Agent shall invest the Settlement Fund in instruments backed by the full faith and credit of the United States Government or fully insured by the United States Government or an agency thereof and shall reinvest the proceeds of these instruments as they mature in similar instruments at the current market rates.
4.2 The Escrow Agent shall not disburse the Settlement Fund except as provided in the Stipulation, or by an order of the Court (consistent with the terms of the Stipulation), or with the written agreement of counsel for the Defendants and Lead Plaintiffs Counsel.
4.3 Subject to such further order and direction by the Court as may be necessary, the Escrow Agent is authorized to execute such transactions on behalf of the Settlement Class Members as are consistent with the terms of the Stipulation.
4.4 All funds held by the Escrow Agent shall be deemed and considered to be in custodia legis of the Court, and shall remain subject to the jurisdiction of the Court, until such time as such funds shall be distributed pursuant to the Stipulation and/or further order(s) of the Court consistent with the terms of the Stipulation.
4.5 Within five (5) days after preliminary approval of this Stipulation as provided in ¶ 5.1 below, STI shall cause the Notice and Administration Fund to be sent to the Claims Administrator to be used solely for costs and expenses reasonably and actually
- 12 -
incurred in connection with providing notice to the Settlement Class, locating Settlement Class Members, soliciting Settlement Class claims, assisting with the filing of claims, administering and distributing the Settlement Fund to Members of the Settlement Class, processing Proofs of Claim and Releases, and paying escrow fees and costs, if any. The Claims Administrator shall have the right to use the funds in the Notice and Administration Fund to pay the first $50,000.00 in costs and expenses reasonably and actually incurred in connection with providing notice to the Settlement Class, locating Settlement Class Members, soliciting Settlement Class claims, assisting with the filing of claims, administering and distributing the Settlement Fund to Members of the Settlement Class, processing Proofs of Claim and Releases, and paying escrow fees and costs, if any, provided that the Claims Administrator sends copies of receipts for all such costs and expenses to counsel for STI.
4.6 Neither Defendants nor their counsel shall have any further responsibility for the costs and expenses reasonably and actually incurred in connection with providing notice to the Settlement Class, locating Settlement Class Members, soliciting Settlement Class claims, assisting with the filing of claims, administering and distributing the Settlement Fund to Members of the Settlement Class, processing Proofs of Claim and Releases, and paying escrow fees and costs, if any, above the Notice and Administration Fund. Any costs and expenses reasonably and actually incurred in connection with providing notice to the Settlement Class, locating Settlement Class Members, soliciting Settlement Class claims, assisting with the filing of claims, administering and distributing the Settlement Fund to Members of the Settlement Class, processing Proofs of Claim and Releases, and paying escrow fees and costs, if any, above the Notice and Administration Fund shall be paid from the Settlement Fund.
4.7 On the Effective Date, any balance (including interest) then remaining in the Notice and Administration Fund, less expenses incurred but not yet paid, must be transferred by the Claims Administrator to STI.
- 13 -
4.8 All costs and expenses associated with the Settlement, the Settlement Fund, including but not limited to any taxes, administrative costs, and costs of providing notice of the proposed Settlement to the Settlement Class, over and above the $50,000.00 available in the Notice and Administration Fund, shall be paid from the Settlement Fund, and in no event shall any of the Defendants, Lead Plaintiffs, Settlement Class Members, or their counsel bear any responsibility for any such costs or expenses.
(b) Taxes
4.9 (a) The Parties and the Escrow Agent agree to treat the Settlement Fund as being at all times a qualified settlement fund within the meaning of Treas. Reg. Section 1.468B-1. In addition, the Escrow Agent and, as required, the Defendants and the Defendants insurer contributing any settlement consideration shall jointly and timely make the relation-back election (as defined in Treas. Reg. Section 1.468B-1) back to the earliest permitted date. Such election shall be made in compliance with the procedures and requirements contained in such regulations. It shall be the responsibility of the Escrow Agent to timely and properly prepare, and deliver the necessary documentation for signature by all necessary parties, and thereafter to cause the appropriate filing to occur.
(b) For the purposes of Section 468B of the Internal Revenue Code of 1986, and Treas. Reg. Section 1.468B, the administrator shall be the Escrow Agent. The Escrow Agent shall timely and properly file all informational and other tax returns necessary or advisable with respect to the Settlement Fund (including, without limitation, the returns described in Treas. Reg. Section 1.468B-2(l)). Such returns (as well as the election described in ¶ 4.9(a)) shall be consistent with this ¶ 4.9 and in all events shall reflect that all taxes (including any estimated taxes, interest or penalties) on the income earned by the Settlement Fund shall be paid out of the Settlement Fund as provided in ¶ 4.9(c) hereof.
(c) All (i) taxes (including any estimated taxes, interest or penalties) arising with respect to the income earned by the Settlement Fund (Taxes), and (ii) expenses and costs incurred in connection with the operation and implementation of
- 14 -
this ¶ 4.9 (including, without limitation, expenses of tax attorneys and/or accountants and mailing and distribution costs and expenses relating to filing (or failing to file) the returns described in this ¶ 4.9) (Tax Expenses), shall be paid out of the Settlement Fund; in all events the Released Persons shall not have any liability or responsibility for the Taxes, the Tax Expenses, or the filing of any tax returns or other documents with the Internal Revenue Service or any other state or local taxing authority. The Escrow Agent shall indemnify and hold the Released Persons harmless for Taxes and Tax Expenses (including, without limitation, Taxes payable by reason of any such indemnification). Further, Taxes and Tax Expenses shall be treated as, and considered to be, a cost of administration of the Settlement and shall be timely paid by the Escrow Agent out of the Settlement Fund without prior order from the Court, and the Escrow Agent shall be obligated (notwithstanding anything herein to the contrary) to withhold from distribution to Authorized Claimants any funds necessary to pay such amounts (as well as any amounts that may be required to be withheld under Treas. Reg. Section 1.468B-2(1)(2)); the Released Persons are not responsible and shall have no liability therefor, or for any reporting requirements that may relate thereto. The Parties hereto agree to cooperate with the Escrow Agent, each other, and their tax attorneys and accountants to the extent reasonably necessary to carry out the provisions of this ¶ 4.9.
c. Termination
4.10 In the event that the Stipulation is not approved, or is terminated, canceled, or fails to become effective for any reason, the Settlement Fund (including accrued interest), less the costs of notice to the Settlement Class incurred pursuant to ¶ 4.8 herein, and less any Taxes or Tax Expenses paid or incurred pursuant to ¶ 4.9 herein shall be refunded to the Defendants Insurer.
4.11 In the event that the Stipulation is not approved, or is terminated, canceled, or fails to become effective for any reason, the Notice and Administration Fund (including accrued interest) less the costs of notice to the Settlement Class incurred pursuant to ¶ 4.5 herein, shall be refunded to STI.
- 15 -
5. | Notice Order And Settlement Hearing |
5.1 Promptly after execution of the Stipulation, but in no event later than ten (10) days after the Stipulation is signed (unless such time is extended by the written agreement of Lead Plaintiffs Counsel and counsel for the Defendants), the Parties shall submit the Stipulation together with its Exhibits to the Court and shall jointly apply for entry of an order (the Notice Order), substantially in the form and content of Exhibit A hereto, requesting that the Settlement Class be certified, the preliminary approval of the settlement set forth in the Stipulation, and approval for the mailing and publication of a Notice of Pendency and Proposed Settlement of Class Action which shall include the general terms of the settlement set forth in the Stipulation, the proposed Plan of Allocation, the general terms of the Fee and Expense Application (as defined in ¶ 8.1) and the date of the Settlement Hearing (as defined below in ¶ 5.2).
5.2 The Parties shall request that, after notice is given, the Court hold a Hearing (the Settlement Hearing) and finally approve this settlement as set forth herein. At or after the Settlement Hearing, Lead Plaintiffs Counsel also will request that the Court approve the proposed Plan of Allocation and the Fee and Expense Application.
6. | Releases |
6.1 Upon the Effective Date, the Representative Plaintiffs shall release, relinquish and discharge, and each of the Settlement Class Members shall be deemed to have, and by operation of the Judgment shall have, fully, finally, and forever released, relinquished and discharged all Released Claims (including Unknown Claims) against each and all of the Released Persons, whether or not such Settlement Class Member executes and delivers the Proof of Claim and Release.
6.2 Upon the Effective Date, each of the Defendants shall be deemed to have, and by operation of the Judgment shall have, fully, finally, and forever released, relinquished and discharged the Representative Plaintiffs, the Settlement Class Members, and Representative Plaintiffs Counsel from all claims (including Unknown Claims),
- 16 -
arising out of, relating to, or in connection with the institution, prosecution, assertion or resolution of the Class Action or the Released Claims.
6.3 Upon the Effective Date, the Representative Plaintiffs, the Settlement Class Members, and Representative Plaintiffs Counsel shall be deemed to have, and by operation of the Judgment shall have, fully, finally, and forever released, relinquished and discharged the Released Persons from all claims (including Unknown Claims), arising out of, relating to, or in connection with the defense, or resolution of the Class Action or the Released Claims.
6.4 Except as otherwise expressly provided for in this Stipulation, the Settling Parties shall each bear their own respective attorneys fees, expenses and costs incurred in connection with the conduct and settlement of the Class Action, and the preparation, implementation and performance of the terms of this Stipulation.
6.5 Only those Settlement Class Members filing valid and timely Proofs of Claim and Release shall be entitled to participate in the settlement and receive any distributions from the Settlement Fund. The Proofs of Claim and Release to be executed by the Settlement Class Members shall release all Released Claims against the Released Persons, and shall be substantially in the form and content of Exhibit A-3 hereto. All Settlement Class Members shall be bound by the releases set forth therein whether or not they submit a valid and timely Proof of Claim and Release.
7. | Administration And Calculation Of Claims, Final Awards And Supervision And Distribution Of Settlement Fund |
7.1 Lead Plaintiffs Counsel, or its authorized agents, acting on behalf of the Settlement Class, and subject to the supervision, direction and approval of the Court, shall administer and calculate the claims submitted by Settlement Class Members and shall oversee distribution of that portion of the Settlement Fund that is finally awarded by the Court to Authorized Claimants.
7.2 The Settlement Fund shall be applied as follows:
- 17 -
(a) To pay all unpaid costs and expenses, above the $50,000.00 in the Notice and Administration Fund, reasonably and actually incurred in connection with providing notice to the Settlement Class Members and to current shareholders of STI including, locating Settlement Class Members and current shareholders of STI, soliciting Settlement Class claims, assisting with the filing of claims, administering and distributing the Settlement Fund to the Settlement Class, processing Proofs of Claim and Release and paying escrow fees and costs, if any;
(b) To pay Taxes and Tax Expenses;
(c) To pay Representative Plaintiffs Counsels attorneys fees, expenses and costs, with interest thereon (the Fee and Expense Award), if and to the extent allowed by the Court; and
(d) To distribute the balance of the Settlement Fund (the Net Settlement Fund) to Authorized Claimants as allowed by the Stipulation, the Plan of Allocation or the Court.
7.3 After the Effective Date and subject to such further approval and further order(s) of the Court as may be required, the Net Settlement Fund shall be distributed to Authorized Claimants, subject to and in accordance with the following:
(a) Within sixty (60) days after the mailing of the Notice or such other time as may be set by the Court, each Person claiming to be an Authorized Claimant shall be required to submit to the Claims Administrator a separate completed Proof of Claim and Release as attached to the Notice and substantially in the form and content of Exhibit A-3 hereto, signed under penalty of perjury and supported by such documents as specified in the Proof of Claim and Release and as are reasonably available to the Authorized Claimant.
(b) Except as otherwise ordered by the Court, all Settlement Class Members who fail to timely submit a valid Proof of Claim and Release within such period, or such other period as may be ordered by the Court, or who have not already done so, shall be forever barred from receiving any payments of money or stock pursuant to the
- 18 -
Stipulation and the settlement set forth herein, but will in all other respects be subject to and bound by the provisions of the Stipulation, the settlement and releases contained herein, and the Judgment.
(c) The Net Settlement Fund shall be distributed to the Authorized Claimants in accordance with and subject to the Plan of Allocation to be described in the Notice mailed to Settlement Class Members. The proposed Plan of Allocation shall not be a part of the Stipulation.
7.4 The Released Persons or their counsel shall have no responsibility for, interest in, or liability whatsoever with respect to: (a) the investment or distribution of the Settlement Fund; (b) the Plan of Allocation; (c) the determination or administration of taxes; or (d) any losses incurred in connection with (a), (b) or (c). No Person shall have any claim of any kind against the Released Persons or their counsel with respect to the matters set forth in this paragraph 7 or any of its subparagraphs.
7.5 No Person shall have any claim against the Representative Plaintiffs or their counsel (including Lead Plaintiffs Counsel), or any claims administrator, or other agent designated by Lead Plaintiffs Counsel based on the distributions made substantially in accordance with the Stipulation and the settlement contained herein, the Plan of Allocation or further orders of the Court.
7.6 The Released Persons or their counsel shall have no responsibility for, interest in, or liability whatsoever with respect to the investment or distribution of the Settlement Fund, the Net Settlement Fund, the Plan of Allocation, the determination, administration, calculation or payment of claims, the payment or withholding of taxes, or any losses or liabilities incurred in connection therewith.
7.7 It is understood and agreed by the Settling Parties that any proposed Plan of Allocation of the Net Settlement Fund, including, without limitation, any adjustments to an Authorized Claimants claim set forth therein, is not a material part of the Stipulation and is to be considered by the Court separately from the Courts consideration of the fairness, reasonableness and adequacy of the settlement set forth in the Stipulation,
- 19 -
and any order or proceedings relating to the Plan of Allocation shall not operate to terminate or cancel the Stipulation or affect the finality of the Courts Judgment approving the Stipulation and the settlement set forth herein, including, but not limited to, the release, discharge, and relinquishment of the Released Claims against the Released Persons, or any other orders entered pursuant to the Stipulation.
8. | Representative Plaintiffs Counsels Attorneys Fees And Reimbursement Of Expenses |
8.1 The Representative Plaintiffs or their counsel may submit an application or applications for an order (the Fee and Expense Application) for distributions to them from the Settlement Fund for: (i) an award of attorneys fees up to 30% of the Settlement Fund plus (ii) reimbursement of all expenses and costs, including the fees of any experts or consultants, incurred in connection with prosecuting the Class Action, not to exceed $62,000.00, plus (iii) interest on such attorneys fees, costs and expenses at the same rate and for the same periods as earned by the Settlement Fund (until paid), as may be awarded by the Court.
8.2 The attorneys fees, expenses and costs, including the fees of experts and consultants, as awarded by the Court (the Fee and Expense Award), shall be transferred to Lead Plaintiffs Counsel from the Settlement Fund, within five (5) business days after the Court enters the Judgment or five (5) business days after the Court approves the Fee and Expense Award, whichever is later. Lead Plaintiffs Counsel shall thereafter allocate the Fee and Expense Award among Representative Plaintiffs Counsel in a manner in which Lead Plaintiffs Counsel in good faith believe reflects the contributions of such counsel to the prosecution and settlement of the Class Action; provided, however, that in the event that the Judgment or the Order making the Fee and Expense Award is reversed or modified on appeal, and in the event that the Fee and Expense Award has been paid to any extent, then Representative Plaintiffs Counsel shall within ten (10) business days from any such reversal or modification, refund to the Settlement Fund the fees, expenses, costs and interest previously paid to them from the Settlement Fund, including accrued interest on
- 20 -
any such amount at the average rate earned on the Settlement Fund from the time of withdrawal until the date of refund. Each such Representative Plaintiffs Counsels law firm, as a condition of receiving any portion of such fees and expenses, on behalf of itself and each partner and/or shareholder of it, agrees that the law firm and each of its partners and/or shareholders are subject to the jurisdiction of the Court for the purpose of enforcing this ¶ 8.2 of the Stipulation. Each such Representative Plaintiffs Counsels law firm, as a condition of receiving any portion of such fees and expenses, on behalf of itself and each partner and/or shareholder of it, agrees that the law firm and each of its partners and/or shareholders shall be jointly and severally liable with each other Representative Plaintiffs Counsels law firm that received any part of the Fee and Expense Award for any refund to the Settlement Fund of the fees the fees, expenses, costs and interest previously paid to them from the Settlement Fund, including accrued interest on any such amount at the average rate earned on the Settlement Fund from the time of withdrawal until the date of refund. Without limitation, each such law firm and its partners and/or shareholders agree that the Court may, upon application of Defendants, or Lead Plaintiffs Counsel, on notice to counsel to the Representative Plaintiffs, summarily issue orders, including, but not limited to, judgments and attachment orders, and may make appropriate findings of or sanctions for contempt, against them or any of them should such law firm fail timely to repay fees and expenses pursuant to this ¶ 8.2 of the Stipulation.
8.3 The Released Persons shall have no responsibility for, and no liability whatsoever with respect to, any payment to Lead Plaintiffs Counsel or any Representative Plaintiffs Counsel from the Settlement Fund that may occur before the Effective Date.
8.4 The Released Persons shall have no responsibility for, and no liability whatsoever with respect to, the allocation of the Fee and Expense Award among Representative Plaintiffs Counsel, or any other Person who may assert some claim thereto, or any Fee and Expense Awards that the Court may make in the Class Action.
8.5 The procedure for and the allowance or disallowance by the Court of the Fee and Expense Application are not part of the settlement set forth in the Stipulation, and
- 21 -
are to be considered by the Court separately from the Courts consideration of the fairness, reasonableness and adequacy of the settlement set forth in the Stipulation. Any order or proceedings relating to the Fee and Expense Application, or any appeal from any order relating thereto, shall not operate to terminate or cancel the Stipulation, or affect or delay the finality of the Judgment approving the Stipulation and the settlement of the Class Action set forth herein.
9. | Conditions Of Settlement, Effect Of Disapproval, Cancellation Or Termination |
9.1 The Effective Date of the Stipulation shall be conditioned on the occurrence of all of the following events:
(a) The Defendants Insurer shall have timely transferred or caused to be timely transferred the Settlement Fund to the Escrow Agent as required in ¶ 2, above;
(b) The Court has entered the Notice Order and certified the Settlement Class, as required by ¶¶ 3.1 and 5.1, above;
(c) The Court has entered the Judgment, or a judgment substantially in the form and content of Exhibit B;
(d) The Judgment has become Final, as defined in ¶ 1.9, above;
(e) Counsel for the Defendants has not given notice of intent to exercise the option to terminate the Stipulation and settlement in accordance with the terms of the Supplemental Agreement described in ¶ 9.9.
9.2 Upon the occurrence of all of the events referenced in ¶ 9.1 above, any and all remaining interest or right of the Defendants and their insurers to the Settlement Fund shall be absolutely and forever extinguished.
9.3 Neither a modification nor a reversal on appeal of any Plan of Allocation or of any amount of attorneys fees, costs, expenses and interest awarded by the Court to any of the Representative Plaintiffs Counsel shall constitute a condition to the Effective Date or grounds for cancellation and termination of the Stipulation.
- 22 -
9.4 If any of the conditions specified in ¶ 9.1, above, are not met, then the Stipulation shall be cancelled and terminated unless Lead Plaintiffs Counsel and counsel for Defendants mutually agree in writing to proceed with the Stipulation.
9.5 Unless otherwise ordered by the Court, in the event the Stipulation shall terminate, or be canceled, or shall not become effective for any reason, within five (5) business days after written notification of such event is sent by counsel for Defendants or Lead Plaintiffs Counsel to the Escrow Agent, the Settlement Fund (including accrued interest), less expenses and any costs which have been used to provide notice of the proposed Settlement to the Settlement Class, and less any Taxes and Tax Expenses paid or incurred pursuant to ¶ 4.9 herein, shall be refunded by the Escrow Agent to the Defendants Insurer. In such event, any tax refund owing to the Settlement Fund shall also be refunded and paid to the Defendants Insurer. At the request of the Defendants, the Escrow Agent or its designee shall apply for any such refund and pay the proceeds, less the cost of obtaining the tax refund, to Defendants Insurer.
9.6 Unless otherwise ordered by the Court, in the event the Stipulation shall terminate, or be canceled, or shall not become effective for any reason, within five (5) business days after written notification of such event is sent by counsel for Defendants or Lead Plaintiffs Counsel to the Claims Administrator, the Notice and Administration Fund (including accrued interest), less expenses and any costs which have been used to provide notice of the proposed Settlement to the Settlement Class shall be refunded by the Claims Administrator to STI.
9.7 In the event that the Stipulation is not approved by the Court or the settlement set forth in the Stipulation is terminated or fails to become effective in accordance with its terms, this Stipulation and all negotiations and proceedings relating hereto shall be without prejudice a) to any or all Settling Parties who shall be restored to their respective positions in the Class Action as of February 11, 2005. In such event, the terms and provisions of the Stipulation, with the exception of ¶¶ 1.1-1.27, 3.2, 4.2, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9, 4.10, 4.11, 7.4, 7.5, 7.6, 8.2, 8.3, 8.4, 9.1-9.10 herein, shall have no
- 23 -
further force and effect with respect to the Settling Parties and shall not be used in the Class Action or in any other proceeding for any purpose and any Judgment or Order entered by the Court in accordance with the terms of the Stipulation shall be treated as vacated, nunc pro tunc . No order of the Court or modification or reversal on appeal of any order of the Court concerning the Plan of Allocation or the amount of any attorneys fees, costs, expenses and interest awarded by the Court to the Representative Plaintiffs or any of their counsel shall constitute grounds for cancellation or termination of the Stipulation.
9.8 If a case is commenced in respect to any Defendant under Title 11 of the United States Code (Bankruptcy), or a trustee, receiver or conservator is appointed under any similar law, and in the event of the entry of a final order of a court of competent jurisdiction determining the transfer of the Settlement Fund, or any portion thereof, by or on behalf of such Defendant to be a preference, voidable transfer, fraudulent conveyance or similar transaction, then, as to such Defendant only, the releases given and Judgment entered in favor of such Defendant pursuant to this Stipulation shall be null and void.
9.9 If prior to the Settlement Hearing, Persons who otherwise would be members of the Settlement Class have filed with the Court valid and timely requests for exclusion (Requests for Exclusion) from the Settlement Class in accordance with the provisions of the Notice Order and the Notice given pursuant thereto, and such Persons in the aggregate purchased a number of shares during the Settlement Class Period in an amount greater than the sum specified in a separate Supplemental Agreement between the Parties (the Supplemental Agreement), Defendants shall have the option to terminate this Stipulation in accordance with the procedures set forth in the Supplemental Agreement. The Supplemental Agreement will not be filed with the Court unless and until a dispute among the Parties concerning its interpretation or application arises. Copies of all Requests for Exclusion received, together with copies of all written revocations of Requests for Exclusion, shall be delivered to counsel for Defendants within two (2) days of receipt thereof.
- 24 -
9.10 In the event this Stipulation shall be cancelled as set forth in ¶ 9.7 above, the Settling Parties shall, within two weeks of such cancellation, jointly request a status conference with the Court to be held on the Courts first available date. At such status conference, the Settling Parties shall ask the Courts assistance in scheduling continued proceedings in the Class Action as between the Settling Parties. Pending such status conference or the expiration of sixty (60) days from the Settling Parties joint request for a status conference, whichever occurs first, none of the Settling Parties shall file or serve any further motions on any of the other Settling Parties in connection with this Class Action nor shall any response be due by any Settling Party to any outstanding pleading or motion by any other Settling Party.
10. | Miscellaneous Provisions |
10.1 The Parties (a) acknowledge that it is their intent to consummate this Settlement and Stipulation; and (b) agree to cooperate to the extent necessary to effectuate and implement all terms and conditions of the Stipulation and to exercise their best efforts to accomplish the foregoing terms and conditions of the Stipulation.
10.2 Each Individual Defendant warrants as to himself or itself that, at the time any of the payments provided for herein are made on behalf of himself or itself, he or it is not insolvent and the payment will not render him or it insolvent. This representation is made by each Individual Defendant as to himself or itself and is not made by counsel for the Individual Defendants.
10.3 The Parties agree that the amount of the Settlement Fund, as well as the other terms of the settlement were negotiated in good faith by the Parties and reflect a settlement that was reached voluntarily after consultation with experienced legal counsel. Neither the Stipulation nor the Settlement contained therein, nor any act performed or document executed pursuant to or in furtherance of the Stipulation or the Settlement: (i) is or may be deemed to be or may be used as an admission of, or evidence of, the validity of any Released Claim, or of any wrongdoing or liability of the Released Persons; or (ii) is or may be deemed to be or may be used as an admission of, or evidence of, any fault or
- 25 -
omission of any of the Released Persons in any civil, criminal or administrative proceeding in any court, administrative agency or other tribunal. Released Persons may file the Stipulation and/or the Judgment from this action in any other action that may be brought against them in order to support a defense or counterclaim based on principles of res judicata , collateral estoppel, release, good faith settlement, judgment bar or reduction or any theory of claim preclusion or issue preclusion or similar defense or counterclaim.
10.4 The Settling Parties intend for this settlement to be a final and complete resolution of all disputes asserted or which could be asserted by the Settlement Class Members against the Released Persons with respect to the Released Claims. Accordingly, the Parties agree not to assert in the Class Action or in any other judicial forum that the Class Action was brought or defended in bad faith or without a reasonable basis. Defendants agree not to assert any claim under Rule 11 of the Federal Rules of Civil Procedure or any similar law, rule or regulation, that the Class Action was brought in bad faith or without a reasonable basis. Lead Plaintiffs and the Settlement Class agree not to assert any claim under Rule 11 of the Federal Rules of Civil Procedure or any similar law, rule or regulation that any pleading filed, motion made or position taken by Defendants, or their counsel, in the Class Action was filed, made or taken in bad faith or without a reasonable basis. The Settling Parties agree that the amount paid and the other terms of the Settlement were negotiated at arms length and in good faith by the Settling Parties, and reflect a settlement that was reached voluntarily based upon adequate information and after consultation with experienced legal counsel, and under the supervision of the Mediator.
10.5 To the extent permitted by law, all agreements made and orders entered during the course of the Class Action relating to the confidentiality of information shall survive this Stipulation.
10.6 The waiver by one party of any breach of this Stipulation by any other party shall not be deemed a waiver of any other prior or subsequent breach of this Stipulation.
- 26 -
10.7 All of the Exhibits to the Stipulation are material and integral parts hereof and are fully incorporated herein by this reference.
10.8 In the event that there exists a conflict or inconsistency between the terms of this Stipulation and the terms of any exhibit to be attached hereto, the terms of this Stipulation shall prevail.
10.9 Nothing in this Stipulation, or the negotiations relating thereto, is intended to or shall be deemed to constitute a waiver of any applicable privilege or immunity, including, without limitation, attorney/client privilege, joint defense privilege, or work product immunity.
10.10 The Stipulation may be amended or modified only by a written instrument signed by or on behalf of all Parties or their successors-in-interest.
10.11 The Stipulation, the Exhibits attached hereto and the Supplemental Agreement constitute the entire agreement among the Parties hereto and no representations, warranties or inducements have been made to any party concerning the Stipulation, its Exhibits or the Supplemental Agreement other than the representations, warranties and covenants contained and memorialized in such documents. Except as otherwise provided herein, each party shall bear its own costs.
10.12 Lead Plaintiffs Counsel, on behalf of the Settlement Class, are expressly authorized by the Representative Plaintiffs to take all appropriate action required or permitted to be taken by the Settlement Class pursuant to the Stipulation to effectuate its terms and also are expressly authorized to enter into any modifications or amendments to the Stipulation on behalf of the Settlement Class which they deem appropriate.
10.13 Each counsel or other Person executing the Stipulation or any of its Exhibits on behalf of any party hereto hereby warrants that such person has the full authority to do so. All orders and agreements entered during the course of the Class Action relative to the confidentiality of information shall survive this Stipulation.
- 27 -
10.14 The Stipulation may be executed by facsimile and in one or more counterparts. All executed counterparts and each of them shall be deemed to be one and the same instrument. Counsel for the Parties to the Stipulation shall exchange among themselves original signed counterparts and a complete set of original executed counterparts shall be filed with the Court.
10.15 The Stipulation shall be binding upon, and inure to the benefit of, the successors and assigns of the Settling Parties hereto.
10.16 The Court shall retain jurisdiction with respect to implementation and enforcement of the terms of the Stipulation, and all Parties hereto and their counsel submit to the exclusive jurisdiction of the Court for purposes of implementing and enforcing the settlement embodied in the Stipulation.
10.17 The Stipulation and the Exhibits hereto shall be considered to have been negotiated, executed and delivered, and to be wholly performed, in the State of California, and the rights and obligations of the parties to the Stipulation shall be construed and enforced in accordance with, and governed by, the laws of the State of California without giving effect to that states choice of law principles.
10.18 No press announcement, press release, or other public statement concerning the Settlement may be made by any of the Settling Parties without approval from the other Settling Parties, except as required by law.
- 28 -
10.19 Notices required by this Stipulation shall be submitted either by any form of overnight mail or in person to:
William B. Federman
Stuart W. Emmons
FEDERMAN & SHERWOOD
120 North Robinson, Suite 2720
Oklahoma City, OK 73102
Lead Plaintiffs Counsel
David Siegel
Daniel P. Lefler
Richard H. Zelichov
Pamela K. Graham
IRELL & MANELLA, LLP
1800 Avenue of the Stars, Suite 900
Los Angeles, CA 90067
Defendants Counsel
IN WITNESS WHEREOF, the parties hereto have caused the Stipulation to be executed, by their duly authorized attorneys, as of March 8, 2005.
FEDERMAN & SHERWOOD | ||||
|
||||
|
By: | |||
|
||||
|
William B. Federman | |||
|
wfederman@aol.com | |||
|
Stuart W. Emmons | |||
|
swe@federmanlaw.com | |||
|
Federman & Sherwood | |||
|
120 N. Robinson Avenue, Suite 2720 | |||
|
Oklahoma City, Oklahoma 73102 | |||
|
Telephone: (405) 235-1560 | |||
|
Facsimile: (405) 239-2112 | |||
|
||||
|
Lead Plaintiffs Counsel | |||
|
||||
|
and |
- 29 -
|
Arthur R. Angel (214611) | |||
|
The Law Offices of Arthur R. Angel | |||
|
1236 N. Fairfax Avenue | |||
|
Los Angeles, California 90046 | |||
|
Telephone: (323) 656-9085 | |||
|
Facsimile: (323) 656-9085 | |||
|
||||
|
Liaison Counsel for Lead Plaintiffs | |||
|
||||
IRELL & MANELLA LLP | ||||
|
||||
|
By: | |||
|
David Siegel (101355) | |||
|
dsiegel@irell.com | |||
|
Daniel P. Lefler (151253) | |||
|
dlefler@irell.com | |||
|
Richard H. Zelichov (193858) | |||
|
rzelichov@irell.com | |||
|
Pamela K. Graham (216309) | |||
|
pgraham@irell.com | |||
|
Irell & Manella LLP | |||
|
1800 Avenue of the Stars, Suite 900 | |||
|
Los Angeles, California 90067 | |||
|
Telephone: (310) 277-1010 | |||
|
Facsimile: (310) 203-7199 | |||
|
||||
|
Attorneys for Defendants |
- 30 -
EXHIBIT 31.1
Statement Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by
Principal Executive Officer and Principal Financial Officer
Regarding Facts and Circumstances Relating to Exchange Act Filings
I, Jeffrey A. Quiram, certify that: | ||||
1. | I have reviewed this quarterly report on Form 10-Q of Superconductor Technologies Inc.; | |||
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |||
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |||
c) | Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |||
d) | Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting. |
5. | The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): |
a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and | |||
b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting. |
Date: May 6, 2005
|
/s/ Jeffrey A. Quiram | |||||
Jeffrey A. Quiram | ||||||
President and Chief Executive Officer |
EXHIBIT 31.2
Statement Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by
Principal Executive Officer and Principal Financial Officer
Regarding Facts and Circumstances Relating to Exchange Act Filings
I, Martin S. McDermut, certify that: | ||||
1. | I have reviewed this quarterly report on Form 10-Q of Superconductor Technologies Inc.; | |||
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |||
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |||
c) | Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |||
d) | Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting. |
5. | The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): |
a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and | |||
b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting. |
Date: May 6, 2005
|
/s/ Martin S. McDermut | |||||
Martin S. McDermut | ||||||
Senior Vice President, Chief Financial Officer and Secretary |
EXHIBIT 32.1
Statement Pursuant to Section 906 the Sarbanes-Oxley Act of 2002
By
Principal Executive Officer and Principal Financial Officer
Dated: May 6, 2005
I, Jeffrey A. Quiram, Chief Executive Officer of Superconductor Technologies Inc, herby certify that, to my knowledge, that:
1. the accompanying Quarterly Report on Form 10-Q of Superconductor Technologies for the three month period ended April 2, 2005 (the Report) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities and Exchange Act of 1934, as amended; and
2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Superconductor Technologies Inc.
IN WITNESS WHEREOF, the undersigned has executed this Statement as of the date first written above.
|
/s/ Jeffrey A. Quiram | |||||
Jeffrey A. Quiram | ||||||
President and Chief Executive Officer |
EXHIBIT 32.2
Statement Pursuant to Section 906 the Sarbanes-Oxley Act of 2002
By
Principal Executive Officer and Principal Financial Officer
Dated: May 6, 2005
I, Martin M. McDermut, Senior Vice President, Chief Financial Officer and Secretary of Superconductor Technologies Inc, herby certify that, to my knowledge, that:
1. the accompanying Quarterly Report on Form 10-Q of Superconductor Technologies for the three month period ended April 2, 2005 (the Report) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities and Exchange Act of 1934, as amended; and
2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Superconductor Technologies Inc.
IN WITNESS WHEREOF, the undersigned has executed this Statement as of the date first written above.
|
/s/ Martin S. McDermut | |||||
Martin S. McDermut | ||||||
Senior Vice President, Chief Financial Officer and Secretary |